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ABSTRACT 
 
The increasing prevalence of drug-resistant pathogens is an urgent problem that requires novel 
methods of bacterial control. Plant extracts inhibit bacterial pathogens and could contain 
antibacterial compounds with novel mechanisms of action. Yerba mate, a common South 
American beverage made from Ilex paraguariensis, has antibiotic activity against a broad range 
of bacterial pathogens. In this work, an attempt was first made to characterize the antibacterial 
source of an aqueous yerba mate extract by generating a series of extract fractions, collecting 
GC-MS and antibacterial activity profiles, and then ranking the hundreds of compounds by their 
presence in fractions with high antibacterial activity. Quinic acid, quercetin, and 5-hydroxy 
pipecolic acid were highly ranked, suggesting an association between the antibacterial activity of 
yerba mate against methicillin-resistant Staphylococcus aureus (MRSA). Next, metabolites that 
accumulated in the supernatants of Salmonella Typhimurium and Lactobacillus casei cultures 
were surveyed for decreases in phenolic compounds that might signify metabolism of bioactive 
yerba mate components. No decreases in phenolic compounds were observed. The hypothesis 
that phenolic compounds might chelate iron as a mechanism of antibacterial activity was also 
tested; exogenous iron sulfate stimulated the partial recovery of S. Typhimurium to the inhibitory 
effect of yerba mate in a milk system. Finally, an assessment of potential antibacterial 
mechanisms of action was undertaken by surveying the metabolites produced by Salmonella 
Typhimurium in the presence of yerba mate extract and conducting assays to assess cell 
membrane integrity and catalase activity. No effect on the cell membrane was observed while 
catalase activity was reduced in the presence of yerba mate extract. Metabolomics revealed 
significant differences in central carbon metabolism, the cell wall precursor UDP-N-
acetylglucosamine, the regulatory metabolites alpha-ketoglutarate and acetylphosphate, the 
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energy metabolite NAD
+
, and a match to yohimbine, which has known antibacterial activity. 
Future work can move closer to understanding the antibacterial value of yerba mate extract and 
its constituents by testing specific mechanistic hypotheses based on metabolic alterations, further 
examining 5-hydroxy pipecolic acid and yohimbine for antibacterial activity and mechanism, and 
annotating currently unknown compounds that could have antibacterial activity or be additional 
key metabolites pointing to specific mechanisms of action. 
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CHAPTER I  
INTRODUCTION 
 
Emergence of antibiotics 
The germ theory of disease proposed by Louis Pasteur and Robert Koch changed popular 
approaches to medicine in the late 1800s and encouraged “chemotherapy” treatments with 
antiseptic chemicals. However, internal bacterial infections remained a major problem, 
particularly as fatal secondary infections of influenza victims in the 1918 pandemic (reviewed by 
Brundage & Shanks, 2008). A solution came serendipitously to Alexander Fleming, who 
observed that a contaminating mold (Penicillium notatum) prevented the growth of bacteria on 
an unattended agar plate  (Fleming, 1929). Despite a delay of more than a decade in gaining 
recognition and mass production, the mold-produced penicillin stimulated the golden age of 
antibiotics in the 1950s, during which many novel compounds with new mechanisms of action 
were discovered and put to use in combating human and animal bacterial disease. Unfortunately, 
the beginnings of a new threat presented itself as strains of penicillin-resistant staphylococci 
were noted, and were associated with “adaptation” (Abraham et al., 1941) to penicillin. Since 
then, selection pressure for bacterial pathogens with resistance mechanisms have led to rising 
populations of pathogens with resistance to many common antibiotics; there are thus fewer and 
fewer treatment options remaining for infections of these bacteria (reviewed by Levy & 
Marshall, 2004). The urgency of this problem is highlighted by a study published less than a 
month ago that reported on a strain of E. coli with resistance to colistin, a “last resort” 
antibacterial, that was found in the U.S. for the first time (McGann et al., 2016). The ever-
increasing presence of multi-drug resistant bacteria has pushed the search for new compounds 
and new mechanisms of action, but the search strategies of the 1950s, which focused on bacterial 
and fungal-derived compounds and their synthetic derivatives (reviewed by Lewis, 2013), seem 
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to be unfruitful in finding new antibacterial drugs. This has promoted a recent trend of searching 
other domains of life, including plants, for novel antibacterial compounds.  
Antibacterial resistance overview 
Antibacterial resistance exists through alterations in antibacterial-targeted cell structures, the 
modification or metabolism of the antibacterial, reduced permeability of the cell, and active 
efflux pumps that remove antibacterial compounds from the cell (Figure 1). Common 
antibacterial classes have distinct mechanisms of action that result in distinct resistance 
mechanisms. Beta-lactams act on the cell wall by binding penicillin-binding proteins, so 
resistance mechanisms include mutant penicillin binding proteins and beta-lactamase enzymes 
that degrade beta-lactam antibacterials. Macrolides, tetracyclines, aminoglycosides, and 
oxazolidinones all act on the ribosome (reviewed by Walsh et al., 2003) but in different binding 
locations, resulting in resistance mechanisms based on binding site mutations, modification of 
the antibacterial, and efflux by efflux pumps (reviewed by Wilson, 2014). Fluoroquinolones 
target DNA gyrase, so DNA gyrase mutants, altered cell permeability, and efflux pumps are 
mechanisms of fluoroquinolone resistance. Membrane permeability changes and efflux pumps 
can specifically exclude or remove certain chemical classes, or they can act non-specifically to 
prevent multiple classes of chemicals from entering the cells or to actively export them 
(reviewed by Kumar & Schweizer, 2005).  
 This dissertation focuses on two globally relevant bacterial pathogens: methicillin-
resistant Staphylococcus aureus (MRSA), which has been implicated in thousands of deaths 
annually in the U.S. (CDC, 2013), and Salmonella enterica serovar Typhimurium, which was 
implicated in 30 deaths and thousands of infections in the U.S. in 2014 (CDC, 2015). 
3 
 
The most obvious approach to combat growing antibacterial resistance is to find new 
antibacterial compounds, but traditional search strategies of screening for inhibitory activity tend 
to rediscover the same compounds and directed high-throughput screens have had limited 
success; screening strategies have been limited by proper target selection and limited chemical 
diversity (reviewed by Silver, 2011). Natural products, though, could be a viable source of 
diverse chemical structures that are capable of inhibiting pathogenic bacteria by novel 
mechanisms, as this dissertation will explore.  
There are alternative, cooperative strategies to discover novel compounds that are also 
being considered. With the increasingly limited effectiveness of existing antibacterial 
compounds, social and cultural strategies to carefully regulate antibacterial use have been 
proposed. These strategies include better tracking of the spread of resistance to guide control 
methods, halting the prophylactic use of sub-therapeutic concentrations of antibacterials in 
domestic animals and plants, isolating hospitalized individuals with multi-drug resistant (MDR) 
infections, and working with healthcare providers to differentiate viral from bacterial infections 
(reviewed by Levy & Marshall, 2004). Since the development of resistance will remain an issue 
even with novel antibacterials that have novel mechanisms of action, social strategies will likely 
be necessary to maintain effective antibacterial treatments. 
Additional strategies to combat antibacterial resistance by interfering with virulence 
factors (i.e. toxins, quorum sensing) are also an active area of investigation and show promise for 
inhibiting disease-causing traits of bacterial pathogens without selecting for resistance in the 
population (reviewed by Bhardwaj, Vinothkumar, & Rajpara, 2013; Hauser, Mecsas, & Moir, 
2016). The monoclonal antibody raxibacumab was approved by the FDA in 2012 for binding 
anthrax toxin in anthrax infections and three other monoclonal antibody inhibitors are currently 
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undergoing clinical trials (shigamab, bexlotoxumab, MEDI4893) (reviewed by Hauser et al., 
2016). Phage therapy and microbiome modulation are also potential strategies to fight bacterial 
pathogens that may redirect selective pressures so that alternating treatment strategies can be 
applied (reviewed by Hauser et al., 2016). 
Plants as sources of novel antibacterial compounds 
Although alternatives to traditional antibacterial drugs are in development, they are not at a stage 
where they can be applied as regular treatment options for major MDR pathogens, so the 
continued search for novel compounds in natural products with diverse structures and novel 
mechanisms of action is still a valuable route of exploration. An extensive review of the 
antimicrobial use of plants by humans has suggested that phytochemicals in particular will be 
important in the discovery of novel therapeutics (Cowan, 1999). More recent studies have 
validated the potential for specific phytochemicals to effectively inhibit pathogenic bacteria with 
known antimicrobial resistance both alone and in synergy with other compounds; in one example 
a  compound blocked the non-specific resistance mechanism of efflux pumps and another 
compound exerted a toxic effect (Tegos, Stermitz, Lomovskaya, & Lewis, 2002). Many whole 
plant extracts have also been observed to have antibacterial activity against bacterial pathogens, 
but only a subset of these studies have actually delved into the mechanistic questions that must 
be addressed in order to understand the circumstances under which a botanical can effectively 
inhibit bacterial pathogens. 
This work focused on an initial characterization of the antibacterial activity of an aqueous 
extract of yerba mate. Yerba mate is a beverage prepared from the heat-processed leaves of Ilex 
paraguarienses and has a long history of human use in South American culture. It has been 
found to have antibacterial activity against Staphylococcus aureus, methicillin-resistant 
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Staphylococcus aureus (MRSA), Salmonella, Listeria, and pathogenic Escherichia coli (Burris, 
Davidson, Stewart, & Harte, 2011; Burris, Higginbotham, & Stewart, 2015; El-Sonbaty & 
Araby, 2014; Girolometto, Avancini, Carvalho, & Wiest, 2009; Gonzalez-gil et al., 2014; Martin 
et al., 2013; Rempe et al., 2015). As an extract that is “generally recognized as safe” (GRAS) by 
the U.S. Food and Drug Administration (FDA) for human consumption (electronic Code of 
Federal Regulations, subpart A, 182.20), it could be a useful antibacterial additive to foods and 
might contain bioactive components with novel antibacterial mechanisms. Yerba mate is known 
to contain a diverse array of phytochemicals, including polyphenolics, xanthine alkaloids (the 
stimulants caffeine, theobromine, and theophylline), and saponins (Heck & De Mejia, 2007). 
Phytochemical classes with known antibacterial activity include phenolics, terpenoids, alkaloids, 
lectins, polypeptides, and polyacetylenes (Cowan, 1999). Phenolic compounds are abundant in 
yerba mate and include the antibacterial compounds quercetin, kaempferol, caffeoylquinic acids, 
and feruloylquinic acids (Heck & De Mejia, 2007).  Although these compounds should 
contribute to the antibacterial activity of yerba mate, no previous attempts have been made to 
determine whether one of these phenolics or another compound was the major contributor to 
antibacterial activity. Furthermore, while mechanisms of quercetin and kaempferol alone have 
been assayed, no previous attempts have been made to survey the mechanisms of action of the 
whole extract. This dissertation reviews the known mechanisms of action of plant phenolic 
compounds, reports an initial effort to identify the constituents of yerba mate contributing to 
antibacterial activity against MRSA, and investigates the major mechanisms of action enacted by 
the whole extract against S. Typhimurium.  
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Scope of dissertation 
This dissertation is organized into 6 chapters.  This introduction provides a short history of 
antibacterial development, mechanisms of antibacterial resistance and strategies to overcome 
antibacterial resistance, and an overview of plants as a source of antibacterial compounds with a 
focus on yerba mate. Chapter 2 discusses the known mechanisms of action of phenolic 
compounds and the role of systems biology methods in discovering novel mechanisms of action. 
Chapters 3-5 encompass the breadth of the research; Chapters 3 is a published peer-reviewed 
article, Chapter 4 is unpublished, and Chapter 5 will be submitted for peer-reviewed publication.  
Chapter 3 investigated the yerba mate compounds that contributed to antibacterial activity 
against methicillin-resistant Staphylococcus aureus based on the computational comparison of 
yerba mate fractions with differing antibacterial activities. Chapter 4 evaluated the accumulated 
metabolites of Salmonella Typhimurium and Lactobacillus casei grown in the presence of yerba 
mate in a milk system. Chapter 5 assessed the metabolic pathways of Salmonella Typhimurium 
at time points selected to glean information into the mechanisms of action of yerba mate extract. 
Finally, conclusions and future research directions are discussed in Chapter 6.   
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Appendix 
Figures 
 
 
Figure 1. Bacterial mechanisms of resistance to antimicrobials. Inability of antimicrobial to 
cross cell barrier (decreased penetration), active membrane pump to shuttle out toxic compounds 
from within the cell (efflux pump), enzymatic degradation of antimicrobials (modification or 
inactivation of enzymes), and modification of the target site (prevents binding) (adapted from 
Abreu et al., 2012). 
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CHAPTER II  
SYSTEMS BIOLOGY APPROACHES TO UNRAVELING 
ANTIBACTERIAL MECHANISMS OF PLANT PHENOLIC COMPOUNDS  
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A version of this chapter will be submitted to the Journal of Applied Microbiology for peer-
reviewed publication by Caroline S. Rempe, Kellie P. Burris, Scott C. Lenaghan, and C. Neal 
Stewart, Jr.: 
 
CS Rempe, SC Lenaghan, KP Burris, and CN Stewart, Jr. contributed to the conception, writing, 
and revising of this review article.  
Summary 
Drug resistance of bacterial pathogens is a growing problem that can be addressed through the 
discovery of compounds with novel mechanisms of antibacterial activity. Plants offer a plethora 
of compounds that have demonstrated broad antibacterial activity. While plant phenolic 
compounds may provide novel mechanisms of action, only known mechanisms of action have 
been evaluated. With systems biology approaches, antibacterial mechanisms can be assessed 
without the bias of target-directed bioassays to enable the discovery of novel mechanism(s) of 
action against drug resistant microorganisms. 
 Key words: phenolic, antibacterial, mechanisms of action, systems biology 
Introduction 
Each group of multi-drug resistant bacteria has been directly linked to thousands of deaths 
annually across the globe, with resistant Shigella species and Mycobacterium tuberculosis each 
causing more than one million deaths annually (WHO, 2014). In the United States (U.S.), drug 
resistant bacteria are the primary cause of more than 23,000 deaths and 2 million serious 
infections each year, of which resistant Clostridium difficile, Enterobacteriaceae species, and 
Neisseria gonorrhoeae are considered “urgent threats” (CDC, 2013).  These numbers will 
continue to rise as multi-drug resistant bacteria become more prevalent; the recent 
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documentation of colistin-resistant Escherichia coli in the U.S. suggests that even “last resort” 
antibiotics with major side effects are likely to lose their effectiveness (McGann et al., 2016).  
Phenolic compounds found in plants can combat multi-drug resistant bacteria (reviewed by 
Abreu, McBain, & Simões, 2012), but their mechanisms of action must be thoroughly 
characterized before they can be rationally used as antibacterial treatments. Several common 
mechanisms of action have been verified to contribute to the antibacterial activity of phenolic 
compounds, but very few attempts have been made to seek novel mechanisms of action.  
The general structural categories of plant-derived phenolics, as categorized by Cowan 
(1999), include simple phenolics, phenolic acids, quinones, flavonoids/flavones/flavonols, 
coumarins, and tannins. Although phenolics are classified as compounds with a hydroxylated 
aromatic ring, Cowan categorized  flavones as “phenolic structures containing one carbonyl 
group” (Cowan, 1999), which prompted the inclusion of flavones in this work. A useful review 
of phytochemical classes and their general antibacterial modes of action has already been 
compiled (Borges, Saavedra, & Simões, 2015), as has as a detailed review of flavonoid 
mechanisms of action, including cytoplasmic membrane damage, topoisomerase inhibition, 
NADH-cytochrome c reductase inhibition, and ATP synthase inhibition (Cushnie & Lamb, 
2011). More recent flavonoid reviews have focused on mechanisms of action involving cell 
membranes (Tsuchiya, 2015; Verstraeten, Fraga, & Oteiza, 2015). The mechanisms of action of 
phenolic compounds were additionally reviewed with an emphasis on structural features 
correlated to specific mechanisms (Gyawali & Ibrahim, 2014).  
Most methods to determine antibacterial mechanisms are target-directed assays that 
directly test single proteins or other cellular targets in vitro. These target-directed methods are 
required to fully understand mechanisms of action, but they have no chance of identifying novel 
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targets since activity assays only assess whether or not the pre-selected target was inhibited. An 
expansion to undirected systems biology approaches that survey all targets within the detection 
range for a given technology will allow for the identification of novel mechanisms of action that 
can combat multi-drug resistant bacterial pathogens. Target-directed assays are very informative 
since established bioassay protocols against a single target can definitively assign binding and 
inhibitory activity of compounds with enzymes known to be essential to cell survival. However, 
target-directed assays also limit the scope of mechanisms that can be identified, which is 
undesirable when existing antibacterial mechanisms of action threaten to become obsolete with 
the rise of resistant bacteria. This is where undirected approaches like systems biology have 
value, in the broad, unbiased survey of possible mechanisms that can be used to formulate new 
hypotheses for novel target-directed assays. 
In this review, we aim to assess the current state of mechanistic investigations of plant 
phenolic antibacterial compounds and survey systems biology approaches that have successfully 
contributed to determining antibacterial mechanisms.  
Membrane disruption by phenolic compounds 
Membrane disruption, in both Gram-positive and Gram-negative bacteria, contributes to the 
antibacterial activity of most plant phenolics that have been mechanistically assessed (Table 1).  
Many of the membrane integrity analyses cited in Table 1 combined several common, simple 
methods to monitor the influx of hydrophobic dyes or antibiotics, the efflux of intracellular 
constituents, and microscopic observation. While these membrane permeability analyses 
provided valuable information about membrane disruption, they gave little, if any, direction to 
the specific major mechanisms of action of a compound. Furthermore, they generally left an 
open question as to whether the compound altered membrane stability by interfering with 
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intracellular processes or by direct interaction with membrane components. Other more unique 
assays have also been conducted, for example, in the quantification of cell surface 
hydrophobicity the tendency of a hydrophilic water drop to spread or bead when in contact with 
a bacterial lawn was measured (Borges, Ferreira, Saavedra, & Simões, 2013). This assay more 
specifically characterized the effect of gallic and ferulic acids, which were observed to increase 
surface hydrophilicity of Gram-negative bacteria and hydrophobicity of Gram-positive bacteria 
(Borges et al., 2013). Nevertheless, this measure of surface hydrophobicity could also be 
attributed to either direct interaction with the membrane or an interaction with intracellular 
components that impact cell wall chemistry.  
Once a membrane effect is known to exist, specific binding assays or model membrane 
insertion assays (T. Wu, He, et al., 2013) can confidently test direct interactions between specific 
components. Model membranes have already been used to test the direct interaction of 
epicatechin gallate and epigallocatechin gallate with membranes (Hashimoto, Kumazawa, Nanjo, 
Hara, & Nakayama, 1999; Kumazawa et al. 2004). However, the extensive diversity in bacterial 
membrane composition (Sohlenkamp & Geiger, 2016) would likely require specific assays with 
each organism of interest. Another unique assay that may be useful in assessing direct membrane 
binding is the addition of exogenous magnesium to a basic membrane integrity assay. This 
assessment revealed a dependence on magnesium akin to an ethylenediaminetetraacetic acid 
(EDTA) control for the membrane-disrupting activity of gallic acid (Nohynek et al., 2006). Since 
magnesium ions are known to stabilize Gram-negative bacterial membranes, this simple assay 
might easily test direct membrane interactions involving magnesium, though other integral cell 
functions involving magnesium should also be considered. 
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A particularly in-depth study was conducted for epigallocatechin gallate’s mechanism of 
action against methicillin-resistant Staphylococcus aureus (MRSA) and its contribution to 
renewed beta-lactam susceptibility. The study assessed purified cell wall components, 
phosphorus content, the effects of exogenous peptidoglycan on activity, adherence to glass, 
penicillin binding protein abundance, Triton-X-100 autolysis, bacteriolytic enzymes, free 
lipoteichoic acid, and lysostaphin’s pentaglycine cleavage activity. Each of these methods 
focused on addressing a particular hypothesis of epigallocatechin gallate’s mechanism of action, 
which is an ideal, albeit time-consuming, approach for a mechanistic assessment. Nevertheless, 
the specific mechanism of action remained unknown despite the new knowledge of 
epigallocatechin gallate’s observed cell adherence, accumulated autolysins, increased 
lipoteichoic acid release, lack of effect on penicillin binding proteins, and reduced effect on 
Triton-X autolysis and lysostaphin lysis (Stapleton, Shah, Ehlert, Hara, & Taylor, 2007). Another 
method that has given mechanistic insight, but not a specific mechanism of action, was the use of 
high resolution gas chromatography (HRGC) lipid profiling to identify specific lipids altered by 
the presence of eugenol, carvacrol, or thymol in both Gram-negative and Gram-positive bacteria 
(Di Pasqua et al., 2007). All three tested phenolics were observed to increase major fatty acids 
(palmitic, oleic, cis-10 heptadecenoic acids) in Gram-negative bacteria while Gram-positive S. 
aureus lipid profiles changed across several fatty acids. S. aureus treatment with thymol, though, 
resulted in a clear increase in saturated fatty acids and decrease in unsaturated fatty acids, which 
could be due to a desaturase response to cell leakage (Di Pasqua et al., 2007). While this type of 
untargeted assessment requires interpretation, it gives a greater depth of information than most of 
the basic membrane disruption assays. When iterations of logically planned assays are 
performed, as in the epigallocatechin example discussed before the HRGC study, a good depth of 
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information is also obtained. However, conducting iterations of assays is time and labor intensive 
while HRGC can gather information on many potential targets simultaneously. Although no 
liquid chromatography-mass spectrometry (LC-MS) lipidomics experiment to deduce the 
mechanisms of action of a phenolic was encountered in the literature, a basic LC-MS experiment 
can measure an even larger range of metabolites than HRGC and more confidently identify them; 
this technology can profile the relative abundance of thousands of lipids simultaneously and is 
easily automated (Wenk, 2005). More untargeted approaches capable of profiling thousands of 
compounds in a single experiment will be useful in the rapid generation of mechanistic 
hypotheses that can subsequently be tested with a relevant subset of targeted assays. 
Non-membrane mechanisms of action 
Assessments for non-membrane mechanisms of action can also be categorized into target-
directed assays for known mechanisms of action and undirected experiments that take a systems-
wide approach to exploring mechanisms of action. Among the plant phenolics tested in Table 1, 
targeted assays have discovered DNA gyrase inhibitory activity for 10 phenolic compounds 
(Ohemeng, Schwender, Fu, & Barrett, 1993; T. Wu, Zang, He, Pan, & Xu, 2013), type III 
secretion inhibition for 9 compounds (Tsou et al., 2016), inhibition of helicase activity for 5 
phenolic compounds (Xu et al., 2001), multi-drug efflux pump inhibitors for 3 compounds (Bag 
& Chattopadhyay, 2014; Fiamegos et al., 2011; E. C. J. Smith et al., 2007),  dehydratase 
inhibition for 3 compounds (Zhang et al., 2008), protein kinase inhibition for 2 compounds 
(Shakya et al., 2011), and single phenolic compounds among which one inhibited urease activity 
(Moon et al., 2013), one bound iron (Chung, Lu, & Chou, 1998), one inhibited succinate 
dehydrogenase and malate dehydrogenase (Yao et al., 2012), one intercalated into DNA (Lou et 
al., 2012), one induced DNA fragmentation, an ROS response, and suppressed FtsZ expression 
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(Hwang & Lim, 2015), and one bound to the FtsZ protein and inhibited FtsZ assembly (Rai, 
Singh, Roy, & Panda, 2008). Many of these results clearly come from a single study picking a 
mechanism of action and screening several phenolic compounds for activity. This approach 
generates valuable information and more such screens are needed to assess phenolic antibacterial 
mechanisms. Nevertheless, the major mechanism(s) of a compound could easily be overlooked 
with a screening approach if multiple mechanisms exist. This problem seems likely when 
looking at one of the most-studied phenolics, quercetin, and its diverse list of mechanisms (cell 
membrane disruption, DNA intercalation, DNA gyrase inhibition, type III secretion inactivation, 
dehydratase inhibition (HpFabZ), and protein kinase inhibition; Table 1).  
A general methodological approach to these targeted assessments was to verify 
antibacterial activity, purify the target enzyme, and characterize its phenolic-bound and unbound 
structures using spectrophotometric techniques. As an example, after gathering antibacterial 
activity data and purifying the FtsZ enzyme, curcumin was observed to inhibit the FtsZ 
protofilament assembly by monitoring assembly kinetics with light scattering, to bind to purified 
FtsZ based on an increase in bound-curcumin fluorescence at 495 nm, and was noted to alter the 
secondary structure of FtsZ based on a circular dichroism analysis (Rai et al., 2008). In some 
studies, however, only inhibitory activity was determined and structural binding characteristics 
were not assessed (Bag & Chattopadhyay, 2014; Ohemeng et al., 1993; E. C. J. Smith et al., 
2007). The most specific interaction details were found by the 2 studies that obtained crystal 
structures of quercetin or apigenin bound to the enzymes they inhibited (Shakya et al., 2011; 
Zhang et al., 2008). One of these studies moved to the next step in mechanistic understanding by 
introducing a single amino acid mutation to the enzyme in order to verify the importance of a 
key binding interaction (Zhang et al., 2008). Unfortunately, the conserved tyrosine that was 
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mutated did not alter binding, so the specific, necessary interaction points between quercetin or 
apigenen and FabZ still need to be validated (Zhang et al., 2008). There were also 2 studies in 
which detailed structure mechanisms were determined with molecular docking, but not further 
validated through single amino acid mutation or crystal structures (Fiamegos et al., 2011; Plaper 
et al., 2003). Detailed structural characterizations of phenolic binding mechanisms are a valuable 
contribution to the field that can facilitate successful computational prioritizations of potentially 
active compounds and predictions of compound activities to guide both natural product testing 
and rational antibacterial design.  
Only one study in Table 1 that is not membrane-specific can be called untargeted: the 
proteomics assessment of thymol antibacterial activity against Salmonella Thompson (Di 
Pasqua, Mamone, Ferranti, Ercolini, & Mauriello, 2010). This study found altered abundances of 
citric acid cycle enzymes, ATP synthesis enzymes, stress-related chaperone proteins, cell 
envelope proteins, and an absence of the antioxidant protein thioredoxin 1 in treated cells. 
Although a specific mechanism of action was not identified here, valuable information was 
produced that verified the cell membrane disruption observed in other thymol-treated Gram-
negative bacteria and added several additional possible protein targets. Additional assays to test 
different portions of the impacted pathways, thioredoxin, and relevant regulatory proteins are 
still needed, of course, but it is now clear that membrane disruption alone was not the sole 
mechanism of action of thymol against S. Thompson and that intracellular proteins, including 
thioredoxin, may be important targets (Di Pasqua et al., 2010).  
Key functional characteristics 
Mechanisms characterized to the level of atomic interaction points are rare in the examples of 
Table 1, but give the most specific mechanistic information. Crystal structures of quercetin and 
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apigenin bound to FabZ showed that quercetin and apigenen, which differ only in 2 hydroxyl 
groups, similarly bind between amino acid groups to block substrates from passing through a 
tunnel to reach the active site (Zhang et al., 2008). Hydrophobic interactions likely sandwich the 
phenolic ring between a tyrosine and proline in one binding site and between a phenylalanine 
and an isoleucine in a second binding site. In the crystal structure of quercetin-bound resistance 
kinases, hydrogen bonds between hydroxyl groups and nearby amino acids appeared to be the 
primary interactions (Shakya et al., 2011). Based on several flavonoids tested, the absence of a 
particular carbonyl group was necessary for binding and the hydroxyl position was important 
(Shakya et al., 2011). A molecular docking study of quercetin and DNA gyrase proposed that 
quercetin has one mechanism by which it binds DNA, stabilizes the DNA-gyrase complex, and 
induces DNA cleavage in addition to a second mechanism by which it inhibits DNA supercoiling 
by competitively binding to the ATP binding site of the DNA gyrase B subunit (Plaper et al., 
2003). Another molecular docking study surveyed the localization of caffeoylquinic acids to an 
efflux pump and determined that caffeoyquinic acids tended to bind in a position that blocked the 
efflux pump (Fiamegos et al., 2011).  
Similar trends in functional groups that contribute to bioactivity are seen in many 
structure activity relationship studies. Electron distribution, as impacted by the number and 
location of hydroxyl groups and double bonds, has been the major factor associated with 
antibacterial activity of flavonoids (reviewed by Gyawali & Ibrahim, 2014; Shapiro & 
Guggenheim, 1998; Wu, Zang, et al., 2013; Wu, He, et al., 2013). Electron localization and other 
structural features also impact molecular hydrophobicity, which impacts the types of membrane 
interactions that are possible.  
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Other studies have found hydroxyl counts and positions to be important for bioactivity 
extending beyond flavonoids and into the broader category of phenolics. A quantitative structure 
activity relationship (QSAR) analysis with more than 100 phenolics and related compounds used 
MIC values against the oral bacteria Porphyomonas gingivalis, Selenomonas artemidis, and 
Streptococcus sobrinus and found that a hydroxyl group attached to an aromatic ring was 
required for low MICs (Shapiro & Guggenheim, 1998). Exceptions to the general trend of key 
hydroxyl placement have been observed through isomers that had different antibacterial 
activities, suggesting that chirality is also an important factor (Friedman, Henika, & Mandrell, 
2002; reviewed by Gyawali & Ibrahim, 2014).  Interestingly, the number of hydroxyl groups has 
also been correlated with antioxidant activity (reviewed by Balasundram, Sundram, & Samman, 
2006; Rice-Evans, Miller, & Paganga, 1996). However, any relationship between antioxidant 
activity and antibacterial activity is not fully understood.  
Synergistic antibacterial activity 
If specific mechanisms of action are known, phenolic compounds can be rationally combined 
with other antibacterial compounds to synergistically combat multi-drug resistant bacteria. 
Synergistic effects have already been observed for many phenolic compounds when combined 
with antibiotics currently in use (reviewed by Aiyegoro & Okoh, 2009; Amin, Khurram, 
Khattak, & Khan, 2015; Hemaiswarya & Doble, 2010; essential oil components reviewed by 
Langeveld, Veldhuizen, & Burt, 2014; Lim et al., 2016; Oh & Jeon, 2015). Many synergistic 
effects have been attributed to membrane-disrupting compounds, including phenolics, that allow 
intracellular toxins faster/easier access to their targets (Amin et al., 2015; Hemaiswarya & Doble, 
2010; Oh & Jeon, 2015). Additionally, strains that use efflux pumps to remove toxins can be 
attacked by blocking the efflux pumps with one compound and applying an intracellular toxin as 
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a second compound for synergistic killing (Oh & Jeon, 2015; reviewed by Prasch & Bucar, 
2015; Tegos & Stermitz, 2002). The down-regulation of efflux pump proteins has also been 
observed (Oh & Jeon, 2015). Synergistic effects between other modes of action may also exist 
and could improve the functionality of existing antibacterial compounds, especially in combating 
drug resistance mechanisms. 
Systems biology methods 
Phenolic compounds from natural sources have been assessed for antibacterial mechanisms 
related to membranes and specific protein and/or pathway targets (Table 1; Figure 2). However, 
most of these assays are limited to target-directed tests of known antibacterial mechanisms and 
do not facilitate the discovery of novel mechanisms of action or multiple mechanisms of action. 
An undirected systems biology approach could reveal the major known and/or unknown 
mechanism(s) of action (Vincent, Ehmann, Mills, Perros, & Barrett, 2016). In particular, -omics 
approaches could reveal unknown mechanisms quickly, with less effort than other systems 
biology approaches. 
Non-omics systems biology approaches include affinity chromatography, which requires 
immobilizing the antibacterial compound in a column, eluting it with any bound proteins, and 
then characterizing the bound protein (reviewed Wong, Cheng, He, & Chen, 2008); phage 
display of translated peptides, which requires several rounds of “biopanning” to remove phage-
displayed peptides that were not bound by the tested antibacterial compound (reviewed Wong et 
al., 2008); and the high-throughput but still time intensive methods of screening for novel targets 
followed by screening for inhibitors of targets (reviewed by Harvey, Edrada-Ebel, & Quinn, 
2015; Miesel, Greene, & Black, 2003; Payne, Gwynn, Holmes, & Pompliano, 2007). Also 
included are time-intensive chemical-chemical interaction approaches that screen the effects of a 
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compound of unknown mechanism in combination with each compound of a diverse set of 
antibiotics with known mechanisms (Farha & Brown, 2010). A recent review discussed another 
major method, the time-consuming construction and screening of genetic mutants for 
antibacterial resistance (Farha & Brown, 2016). This method has had success, but also has the 
potential to simply reveal mechanisms of resistance that are distinct from mechanisms of 
antibacterial action. 
Metabolomics is capable of using µl volumes of extracted samples to gain information on 
potentially thousands of metabolites that define antibacterial mechanisms in 30 min per sample 
for some system platforms (Lu et al., 2010). The major limitations of -omics approaches are the 
ranges of detection for different technologies and the availability of annotated information for a 
given organism. In the metabolomics example, high resolution LC-MS systems can give a good 
representation of major bacterial metabolic pathways, but lipids, high molecular-weight 
compounds, and volatile compounds generally require separate runs on different instrument 
platforms (reviewed by Aretz & Meierhofer, 2016; Dettmer, Aronov, & Hammock, 2007). On 
the annotation aspect, bacterial pathogens have long been a focal point of bacterial research, so 
they are relatively well studied and have readily accessible, consistently annotated data in a 
recent database dedicated to pathogens (Wattam et al., 2014), though annotated genomes and 
metabolomes in general are still far from comprehensive (Aretz & Meierhofer, 2016; Médigue & 
Moszer, 2007). Thus, -omics analyses should be a viable option for determining antibacterial 
mechanisms of uncharacterized compounds. Metabolomics has already proven useful for 
determining mechanisms of action that impact specific metabolic functions.  The mechanisms of 
action of a thymidine kinase inhibitor (AZ1), a 1-deoxy D-xylulose 5-phosphate (DXR) pathway 
inhibitor (fosmidomycin), and a lipid A synthesis inhibitor (CHIR-090) were readily identified 
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with E. coli metabolomics data by data analysts blinded to the antibiotics used (Vincent et al., 
2016). However, in the analysis of other compounds, the metabolomics data showed non-specific 
upregulation of many metabolites for a peptidoglycan cross-linking inhibitor, a DNA ligase 
inhibitor, and an enoyl-acyl carrier protein inhibitor. Furthermore, no discernible metabolic 
differences were observed between a control and an antibiotic treatment that uncoupled the 
proton gradient of the electron transport chain. Measurement limitations in observing 
peptidoglycan molecules (too large) and mono-, di-, and tri-phosphates (differing ionizabilities) 
were possible reasons for the lack of relevant information from the peptidoglycan inhibitor and 
oxidative phosphorylation inhibitor (Vincent et al., 2016). Belenky et al. (2015) were also able to 
differentiate antibacterial compound treatments based on the affected E. coli metabolome after 
60 and 90 min of treatment, but not after 30 min. It was not specified whether the known cellular 
targets of ampicillin, kanamycin, and norfloxacin could be determined from their respective 
metabolomes, but the ROS hypothesis of cell death was supported based on similarly high levels 
of a metabolic marker for DNA/RNA oxidation across all antibiotic treatments (Belenky, Ye, 
Porter, Cohen, et al., 2015). Another metabolomic study successfully used the exometabolome of 
S. aureus to determine the previously unknown antibacterial mechanism of action of 
triphenylbismuthdichloride (TPBC). By comparing the exometabolome of TPBC-treated S. 
aureus to the exometabolomes of kanamycin, ciprofloxacin, trimethoprim, and fluoropyruvate it 
was observed that only TPBC and fluoropyruvate continuously accumulated pyruvate. Thus, the 
pyruvate dehydrogenase inhibition activity of TPBC was hypothesized and then verified by an 
enzyme activity assay with cell lysate (Birkenstock et al., 2012). Another study used a similar 
comparison methodology to hypothesize the mechanism of the non-phenolic plant natural 
product dihydrocucurbitacin F-25-O-acetate. The metabolic profile of S. aureus treated with 
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dihydrocucurbitacin F-25-O-acetate clustered with the metabolic profile of S. aureus treated with 
vancomycin, a known inhibitor of peptidoglycan synthesis (Biao-Yi, Yu, & Zeng-Liang, 2008).  
A scheme to classify compounds into known mechanisms of action was also recently 
used with NMR metabolomics, where a partial least squares discriminant analysis  of the 
metabolic “fingerprints” of E. coli treated with one of 9 antibiotics of known mechanism gave 
91% accuracy with intracellular data and 30% accuracy with extracellular data (Hoerr et al., 
2016). Another systems biology approach similarly classified phenotypes based on the Raman 
spectra of dried E. coli cells to distinguish antibacterial mechanisms of action; 15 antibacterial 
compounds representing protein synthesis inhibitors, cell wall synthesis inhibitors, DNA 
synthesis inhibitors, and RNA synthesis inhibitors were differentiable with 83.6% accuracy by 
mechanistic class. Ampicillin was always incorrectly classified with the final model based on a 
linear discriminant analysis of principle components, but overlap between the mechanism groups 
could explain this and other misclassification tendencies (Athamneh, Alajlouni, Wallace, 
Seleem, & Sengera, 2014). Classification schemes like these can only classify data into known 
mechanisms of action. However, unknown mechanisms of action should not group into known 
mechanistic classes and could thus be singled out for further characterization. 
Transcriptomic studies have tended to highlight pathways impacted by an antibacterial 
compound without identifying a specific mechanism of action (Yu et al. 2012, Bionda et al. 
2013, Elnakady et al. 2016), although transcriptional profiling of bacterial mutants revealed 
expression trends that were used to predict phenylalanyl-tRNA synthetase inhibition and 
bacterial acetyl coenzyme A carboxylase inhibition as the primary mechanisms of action of two 
novel antibacterial compounds (C Freiberg, Fischer, & Brunner, 2005). A 2004 review cites 
transcriptomic and proteomic studies that used transcriptomics or proteomics to assess 
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antibacterial mechanisms, some of which were successful in identifying mechanisms of action 
(Christoph Freiberg, Brötz-Oesterhelt, & Labischinski, 2004). More recently, proteomics showed 
its usefulness in mechanistic assessments by providing evidence for a second mechanism of 
action of the atypical tetracycline chelocardin, which inhibits peptidyl transferase at low 
concentrations and causes membrane depolarization at high concentrations in B. subtilis 
(Stepanek, Lukežič, Teichert, Petković, & Bandow, 2016).  
Structural systems pharmacology has also made strides in identifying antibacterial 
mechanisms through combining multiple -omics approaches. A recent study was able to use an 
E. coli K12 genome scale metabolic model integrated with protein structures to correctly predict 
the antibacterial mechanisms of fosfomycin, and sulfathiazole. This model was also able to 
predict additional mechanisms of action for (1-hydroxyheptane-1,1-diyl)bis(phosphonic acid) 
and cholesteryl oleate and predict potential inhibitors of a protein target (tryptophan synthase 
beta subunit) with no previously known inhibitors. However, many false positives were also 
observed, which could be attributed to the static protein structures used to evaluate ligand 
binding (Chang, Xie, Bourne, & Palsson, 2013).  
Systems biology approaches in assessments of phenolic antibacterial mechanisms of 
action are relatively rare:  Nakayama et al. (2015) used proteomics to identify a set of membrane 
proteins that epicatechin gallate may inhibit in Bacillus subtilis (Nakayama et al., 2015) while Di 
Pasqua et al. (2007) used HRGC to evaluate membrane effects of thymol, carvacrol, and eugenol 
and Di Pasqua et al. (2010) used proteomics to identify proteins and pathways altered by thymol. 
Conclusion 
The mechanisms of action of most naturally derived phenolic compounds are not well 
characterized. Of the compounds reviewed here, mechanistic assessments have found specific 
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antibacterial targets, including DNA, DNA gyrase, multi-drug efflux pumps, FabZ, protein 
kinases, helicase, and FtsZ. The identification of these antibacterial targets through target-
directed methods enables the rational use of phenolic compounds against bacterial pathogens 
susceptible to these known mechanisms of action. However, target-directed approaches have no 
opportunity to discover novel mechanisms of action, which is a necessary step to combat multi-
drug resistant bacteria. A systems-biology approach to investigating the antibacterial 
mechanisms of phenolic compounds is not yet common in determining phenolic antibacterial 
mechanisms of action, but will likely push the field forward by speeding up mechanistic 
determinations and removing the bias of testing for currently known mechanisms.     
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Appendix 
Figures 
 
Figure 2. Antibacterial mechanisms of action summarized for A. common antibiotic classes and  
B. plant phenolic compounds (adapted from Helander et al. 1997, Brown et al. 2015,  
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Figure 2 legend continued  
Kohanski et al. 2010). PBP: penicillin binding protein. Effects of exogenous magnesium were 
not tested on a Gram-positive organism, only a Gram-negative organism. 
 
Tables 
Table 1. Known antibacterial mechanisms of action of phenolic compounds. (attachment)
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CHAPTER III 
COMPUTATIONAL RANKING OF YERBA MATE SMALL MOLECULES 
BASED ON THEIR PREDICTED CONTRIBUTION TO ANTIBACTERIAL 
ACTIVITY AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS 
AUREUS 
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Abstract 
The aqueous extract of yerba mate, a South American tea beverage made from Ilex 
paraguariensis leaves, has demonstrated bactericidal and inhibitory activity against bacterial 
pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The gas 
chromatography-mass spectrometry (GC-MS) analysis of two unique fractions of yerba mate 
aqueous extract revealed 8 identifiable small molecules in those fractions with antimicrobial 
activity.  For a more comprehensive analysis, a data analysis pipeline was assembled to prioritize 
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compounds for antimicrobial testing against both MRSA and methicillin-sensitive S. aureus 
using forty-two unique fractions of the tea extract that were generated in duplicate, assayed for 
activity, and analyzed with GC-MS. As validation of our automated analysis, we checked our 
predicted active compounds for activity in literature references and used authentic standards to 
test for antimicrobial activity. 3,4-dihydroxybenzaldehyde showed the most antibacterial activity 
against MRSA at low concentrations in our bioassays.  In addition, quinic acid and quercetin 
were identified using random forests analysis and 5-hydroxy pipecolic acid was identified using 
linear discriminant analysis. We also generated a ranked list of unidentified compounds that may 
contribute to the antimicrobial activity of yerba mate against MRSA.  Here we utilized GC-MS 
data to implement an automated analysis that resulted in a ranked list of compounds that likely 
contribute to the antimicrobial activity of aqueous yerba mate extract against MRSA.  
Introduction 
Antibiotic resistance is a significant problem for human and animal health since the development 
and production of novel antimicrobials has lagged behind the evolution of bacteria for multi-drug 
resistance.  Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogenic biotype of 
global concern because of its resistance to multiple antibiotics (World Health Organization, 
2014). Bioactive plant compounds are a potential source for novel antimicrobial formulations; 
however, the isolation and identification of a novel antimicrobial component among hundreds of 
compounds can be costly and time-consuming.  Therefore, a prioritization of compounds based 
on bioactivity is a useful first step of an efficient antimicrobial discovery process.  
Recent reports have shown that an aqueous extract of yerba mate tea, from the plant Ilex 
paraguariensis, is bactericidal and inhibitory to the growth of bacterial pathogens (Burris et al., 
2011; Burris, Davidson, Stewart, Zivanovic, & Harte, 2012), including MRSA (Burris et al., 
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2015) and could contain one or more novel antimicrobial compounds. Although many compound 
classes could contribute to antimicrobial activity, this study focused on compounds, like 
phenolics, that are readily detected with gas chromatography-mass spectrometry (GC-MS) when 
derivitized with trimethylsilyl (TMS) groups. Small phenolic molecules are known to be 
prevalent in yerba mate (Heck & de Mejia, 2007) and have antimicrobial activity against many 
pathogens, including MRSA (reviewed in Cowan, 1999; Saleem et al., 2010), and so serve as a 
reasonable initial focus in the search for yerba mate antimicrobial constituents.  Phenolics 
previously observed in extracts of yerba mate tea include caffeic acid, caffeoylquinates, 
caffeoylshikimates, dicaffeoylquinates, feruloylquinates, kaempferol, quercetin, and rutin, which 
have been observed to have beneficial properties ranging from antioxidant to antitumor activities 
(reviewed in Heck and de Mejia, 2007). Recently, MRSA-antimicrobial activity of yerba mate 
was characterized (Burris et al., 2015; Martin et al., 2013). In addition, Martin et al. 2013 
identified chlorogenic acid and caffeic acid in the yerba mate extracts to be active against 
bacterial food pathogens, however, these compounds were not tested against MRSA. 
The purpose of our study was to isolate and identify the compounds contributing to yerba 
mate’s antimicrobial activity against MRSA. This study expanded on previous assessments by 
both identifying compounds with antimicrobial activity against MRSA using a unique assembly 
of existing methods and testing authentic standards.  
Materials and methods 
Yerba mate extractions 
Dried leaves of a single commercial brand of yerba mate tea (Taragui; Argentina; 100% leaves; 
I. paraguariensis) were purchased from a local international supermarket. Extracts were obtained  
using previous methods (Burris et al., 2012) with modifications.  Commercial tea leaves were 
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finely ground to a particle size of less than 300 µm using a commercial food blender (Oster, 
Boca Raton, Fla., USA). Sterile deionized water was added to ground leaves at a ratio of 3.6 ml 
to 1 g ground tissue, was allowed to stand for 2 h at 4 °C with occasional mixing to maximize 
extraction and was subsequently centrifuged at 5000 × g for 30 min. Aqueous extracts were then 
subjected to dialysis at 4 °C against deionized water for 36 h using a 3500 MWCO SnakeSkin 
pleated dialysis tubing (ThermoFisher Scientific, Rockford, Ill., USA). Dialyzed extracts were 
then centrifuged at 5000 × g for 30 min to remove large insoluble particles and frozen at -80 °C.  
Frozen extracts were lyophilized using Labconco FreeZone 12 L Freeze Dry System (Labconco, 
Kansas City, Missouri, USA) to concentrate them.  Lyophilized extracts were stored at room 
temperature in a sealed container until testing.   
The lyophilized aqueous extract was subsequently extracted with 10%, 20%, 30%, 40%, 
50%, 60%, 70%, 80%, and 90% solvent (methanol or acetonitrile). Following solvent extraction, 
samples were centrifuged at 13,000 × g for 30 min which separated them into two fractions: the 
pellet (not soluble in solvent concentration) and the supernatant (soluble in solvent 
concentration).  Fractions were subsequently dried using a SpeedVac Concentrator (Savant 
Industries, Inc., Farmingdale, N.Y., USA).  Lyophilized solvent-extracts were weighed, 
resuspended in sterile water to a concentration of 40 mg/ml and stored at -20 °C until testing. 
The GC-MS chromatograms of one initial active and one inactive methanol extract were used to 
select compounds found in the active extract but absent in the inactive extract, and likely to 
contribute to antibacterial activity (sugars were not selected). 
Antimicrobial susceptibility tests 
 MRSA strains ATCC 33591 and ATCC 33593 were purchased from American Type Culture 
Collection (ATCC; Manassas, Va., USA). Methicillin-sensitive Staphylococcus aureus (SA) 
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strains ATCC 27708 and SA 113 were obtained from the Center Environmental Biotechnology 
at the University of Tennessee, Knoxville (courtesy of Steven Ripp). Bacteria were selected on 
Baird-Parker medium (Becton, Dickinson and Co., Sparks, Md., USA) and stock cultures were 
prepared by isolating a single colony, growing in tryptic soy broth (TSB; Becton, Dickinson and 
Co.) and stored at -20 °C in glycerol.  
Solvent extracts were tested for antimicrobial activity by the disk diffusion method 
against MRSA and non-resistant S. aureus (SA). Pure cultures of each bacterial strain were sub-
cultured at least once in Mueller-Hinton broth (Becton Dickinson & Co.) by inoculating 50 ml 
broth with 200 µl stock cultures for 24 h incubation at 35-37 °C.  Following incubation, ca. 9.0 
log10 CFU/ml cultures were diluted to ca. 6.0 log10 CFU/ml and each diluted bacterial suspension 
was swabbed onto Mueller-Hinton agar plates prior to disk placement. Twenty microliters of the 
extract or water control were placed on each 6 mm sterile blank disk (Becton Dickinson & Co.), 
and subsequently plated in duplicate on Mueller-Hinton agar. Plates were incubated for 24 h at 
37 °C and the zones of inhibition of bacteria were measured. 
Two sets of activity assays were performed with authentic standards. The first used 
concentrations based on the approximated ratios of compounds observed in our initial two-
sample GC-MS data (glycolic acid 1 µg/ml, 3,4-dihydroxybenzaldehyde 0.01 µg/ml, citric acid 
31 µg/ml , caffeic acid 46 µg/ml, kaempferol 2 µg/ml, chlorogenic acid 285 µg/ml, 4-O-
caffeoylquinic acid 210 µg/ml, 5-O-caffeoylquinic acid 311 µg/ml, and each of these 
concentrations at 10x). The second set of activity assays tested compounds alone at 10 µg/ml, 20 
µg/ml, and 100 µg/ml. Activity assays for authentic standards alone and in combination were 
carried out using a micro-broth dilution assay. Sterile 96-well microtiter plates with a well 
capacity of 300 µl were used. A total volume of 250 µl was used consisting of 125 µl double 
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strength tryptic soy broth (TSB), 10 µl chemical diluted in 1% dimethyl sulfoxide (DMSO) in 
water, and 25 µl of inoculum (ca. 6.0 log10 CFU/mL). For the second set of activity assays, 
samples were randomly assigned within central, intermediate, and edge locations on each plate to 
minimize edge effects. Only center samples were used in the final analysis. For all tests, 
microtiter plates were covered with a sterile lid and incubated for 24 h to 48 h at 37 
o
C and the 
absorbance (630 nm) of each well was read at 0 h, 8 h, 24 h, and 48 h (for the second bioassay) 
with a microtiter plate spectrophotometer (Elx800 Universal Microplate reader, BioTek 
Instruments, Winooski, Vermont, USA). The micro-broth dilution assays were performed in 
triplicate. Statistical analysis of the data was performed using analysis of variance with mixed 
models in SAS 9.4 (SAS Institute Inc., Cary, N.C., USA) using a randomized block design 
(RBD) blocked on replicate for each single strain separately at 48 h or 24 h. Least squares means 
were separated using Tukey’s significant difference test. Levene tests for equal variance 
(P>0.05) and Shapiro-Wilks tests for normality (W>0.80) were performed using R, and boxplots 
were constructed (R Foundation for Statistical Computing, Vienna, Austria).  
GC-MS sample preparation and instrument parameters 
The samples rehydrated to 40 mg/ml were filtered using 0.2 µm nylon membrane filters (13 mm 
Acrodisc; Pall Corporation, Ann Arbor, Mich., USA). Fifty microliters of each sample (or the 
whole sample if less than 50 µl) and 15 µl of 1 mg/ml liquid sorbitol solution were then dried 
under a stream of sterile flowing nitrogen. Two samples that contained < 50 µl were multiplied 
by a correction factor after feature detection and retention time correction to approximate a 50 µl 
sample. Several samples contained insufficient material for rehydration, filtration, and 
derivitization. We analyzed a total of 60 samples by GC-MS, 34 of which were unique (some 
biological duplicates generated different amounts of material). Dried samples were derivitized by 
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adding 500 µl HPLC grade acetonitrile followed by 500 µl N-methyl-N-
trimethylsilyltrifluoroacetamide (MSTFA) with 1% trimethylchlorosilane (TMCS) (Thermo 
Fisher Scientific) and incubating at 70 °C for 60 min. After 2 d, 1 µl of each sample was injected 
by an autosampler into a GC-MS instrument (Agilent Technologies Inc., Santa Clara, Calif., 
USA) with a 5975C inert XL gas chromatograph-mass spectrometer, fitted with an Rtx-5MS 
with Integra-guard (5% diphenyl/95% dimethyl polysiloxane) capillary column 30 m by 250 µm 
by 0.25 µm of film thickness). This standard quadrupole GC-MS was operated with electron 
impact (EI) ionization at 70 eV, six 50 Da to 650 Da scans per second, and helium gas flow rate 
of 1.33 ml/min with the injection port in splitless mode. Temperatures were held at 250 °C for 
the injection port, 230 °C for the mass spectrometer source, and 150 °C for the mass 
spectrometer quad. The oven was programmed to start at 50 °C for 2 min, ramp up to 325 °C at 
20 °C per min, hold for 11 min, and then cycle back down to 50 °C. Data files were exported to 
AIA format in MSD ChemStation (Agilent Technologies, Inc., Santa Clara, Calif, USA) for 
subsequent analysis. 
Data analysis 
In an initial assessment of methanolic fractions of yerba mate extract, we selected two 
comparable samples, one with antimicrobial activity against MRSA and one without 
antimicrobial activity against MRSA, for GC-MS analysis. The resulting spectra were overlayed 
and GC peaks that were higher in the active samples and lower in the inactive samples were 
identified with the aid of MS libraries when possible.  
The software program XCMS (C. A. Smith, Want, O’Maille, Abagyan, & Siuzdak, 2006) 
was used for both feature detection and retention time correction with parameters based on the 
“GC –EI, Single Quadrupole MS” default values from XCMSOnline (Gowda et al., 2014; 
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Tautenhahn & Patti, 2012). The effectiveness of the feature detection of different parameter sets 
was assessed by plotting detected features onto a heatmap of a single sample with all known 
reference compounds present (Figure S 1). The presence of features at particular reference ions 
of known compounds was assessed alongside general trends of the heatmap topology in order to 
select optimal parameters. The same method was used to evaluate the effectiveness of correcting 
retention time drift by plotting corrected features and uncorrected features on the same single 
sample heatmap.  Final feature detection and retention time correction parameters for XCMS are 
listed in Table S 1. Correction factors for the 2 samples with concentrations less than 50 µl were 
multiplied by intensity values to create a modified matrix that was used for all subsequent 
analyses. There was variation in the sorbitol (internal standard) 319 m/z peak height relative to 
the intensities of other peaks in some samples, which was likely the result of ion suppression 
and/or sample matrix interactions. Therefore, spectral peaks were further adjusted based on the 
319 m/z peak of sorbitol, so that adjusted ion peak = ion peak * average sorbitol 319 m/z peak 
across all spectra/sorbitol 319 m/z peak of current spectrum.  
Linear discriminant analysis (LDA) was implemented as a pseudo-inverse matrix 
calculation using the Python linear algebra library numpy.linalg.pinv. The data matrix from 
XCMS was normalized by subtracting the mean and dividing by the standard deviation for each 
attribute column. To construct a proper discriminant function, a 'bias' feature was added in the 
form of a column of ones. With this, the Python Numpy pseudo-inverse function was used to 
train and test the data with leave-one-out cross-validation sets. Finally, the whole dataset was 
used in training to generate an optimized weight for each attribute. The weight coefficient for 
each attribute in the discriminant function can be seen as an estimate of that attribute's 
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importance in computing the antimicrobial activity. Hence, attributes were ranked from largest to 
smallest weight and assessed for the numbers of known antimicrobial compounds with high rank.  
MetaboAnalyst was used to generate additional ranked peaklists using different methods. Using 
MetaboAnalyst software (Xia, Mandal, Sinelnikov, Broadhurst, & Wishart, 2012), we prioritized 
peaks in ranked lists from fold-change analysis (using proportions of change between two 
sample groups), t-test (using comparison of means between two groups), principal component 
analysis (PCA; using an unsupervised measure across data axis with the most spread), partial 
least squares linear discriminant analysis (PLS-DA; using a supervised measure across data axes 
with most variation), recursive support vector machine (R-SVM; using the supervised data-
separating hyperplanes of several SVMs to rank the top 50 attributes from the t-test), 
significance analysis of microarray (SAM; using significance scores and thresholds to determine 
the significance of single features), empirical Bayesian analysis of microarray (EBAM; using a 
two group mixture model to separate null and significant features based on a delta value of 0.9), 
and random forests (using set of weak decision tree learners which form a strong voting system 
for classification) analyses. MetaboAnalyst parameters for no missing data and autoscaling for 
normalization were selected.  
Lists from PCA were ordered from largest to smallest absolute values of the first 
principal component loading values to assess an unsupervised approach. PLS-DA, LDA, and 
random forests lists were ordered from largest to smallest (not absolute value) since they were 
supervised, and positive values were associated with attributes that discriminated the positive 
class (active) from the negative class (inactive). Lists from statistical tests were kept in order of 
statistical significance (smallest to largest p-values (t-test), smallest to largest log2s (fold 
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change), largest to smallest z-values (EBAM), and largest to smallest d-values (SAM)). Ranking 
weights and statistical values are reported in Table S 2. 
JMP Pro 10 (SAS Institute Inc., Cary, N.C., USA 1989-2007) was used to run logistic regression 
analyses on the top-ranked spectral peaks of quinic acid, quercetin, and 5-hydroxy-pipecolic acid 
using peak intensity as a continuous variable to predict a binary outcome of inactive or active 
against MRSA.  Each model was evaluated based on the whole model test Prob<ChiSq p-value 
and lack of fit Prob<ChiSq p-value being less than 0.05. The parameter estimate of the model 
was then used to reverse predict the classes of the dataset based on the spectral peak to get a 
predictive accuracy.  
Prioritized peak lists were compared in a pairwise fashion using a rank biased overlap 
function implemented with the Python function rbo.py (Agrawal, 2013; Webber, Moffat, & 
Zobel, 2010). This function scored the similarity between the single top-ranked element of each 
list, then scored the similarity between the top two-ranked elements of each list, and so on, in 
overlapping sections to generate an overall score. These scores gave greater weight to the more 
highly ranked elements by using a convergent series of weights, specifically the geometric series 
(Webber et al., 2010). 
The Golm Metabolome Database (GMD) was used to predict functional groups for 
unknown compounds. Each functional group had its own decision tree classifier with a cross-
validation accuracy obtained from the GMD (Hummel, Strehmel, Selbig, Walther, & Kopka, 
2010) that was used to gauge predictive accuracy. The Python library urllib2 was used to 
interface with the GMD in an automated fashion.  
Retention index was calculated from a best-fit line of known compounds based on their 
retention indices in GMD GC-EI-TMS spectra, and their retention times in our data. This 
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calculation was devised from the knowledge that any set of compounds with known retention 
indices can be used to index other compounds from the same spectra (Ettre, 2003). Predicted 
functional groups were summarized for each dataset compilation by counting occurrences of 
each unique predicted group for all unique retention times and for the top ten unique retention 
times.  
Results  
Yerba mate extracts fractionated by varying proportions of acetonitrile (Table S 3) or methanol 
(Table S 4) in water had variable activity against MRSA and SA. In general, fractions with 
higher antimicrobial activity were observed in supernatants extracted with 80% or less methanol 
and 70% or less acetonitrile and in the pellets remaining from the extractions using higher 
percent methanol (>80%) (Table S 4) or acetonitrile (>70%) fractions (Table S 3). The resulting 
activity data was used to label each fraction as ‘active’ (any measure of bacterial growth 
inhibition) or ‘inactive’ (no bacterial growth inhibition) (Table S 3, Table S 4). 
Our initial GC-MS analysis of one spectrum from an antibacterial extract and one 
spectrum from a non-antibacterial extract generated a differential list of 8 non-carbohydrate 
compounds (Figure 3), 4 of which were already known to inhibit MRSA, based on literature 
sources (Table S 5). For our automated spectral analysis of a more robust dataset, our feature 
detection parameters with XCMS resulted in 2204 m/z peaks at unique retention times. Visual 
examination of detected features on a m/z vs. retention time heatmap (Figure S 1) revealed that 
features generally aligned well with high intensity m/z regions of the heatmap. A check for the 
existence of major ions from our 8 known compounds showed that at least one major ion peak 
from caffeic acid, citric acid, and the chlorogenic acids was present. The extracted ion peaks our 
group used for 3,4-dihydroxybenzaldehyde and kaempferol were not detected, but other 
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characteristic peaks of these compounds were observed at their respective retention times. Peaks 
for glycolic acid were not detected.  
In a check for proper retention time correction, features from two different sampling time 
periods were visually observed to improve based on overlays before and after retention time 
correction plotted on a sample heatmap (Figure S 1).  Although there was significant 
improvement, retention time drift correction could still be improved further, as evidenced by 
non-overlapping dots in the corrected plot.  
In general, spectra from extracts of different solvent fractionation methods contained 
many of the same GC peaks, so differences in quantitative information were more relevant to this 
analysis than differences in qualitative information. The ability to rank influential compounds 
would be improved and perhaps more reliable with fractionation methods that generated extracts 
with very qualitatively different compositions. Nevertheless, our analysis of this dataset revealed 
an additional set of three identifiable, and potentially antibacterial, compounds (quinic acid, 
quercetin, and 5-hydroxy-pipecolic acid) in addition to the unknown compounds that ranked with 
known antimicrobials. Since the list ranked by random forests contained the most antimicrobial 
compounds that were known in high ranks, we additionally surveyed compounds at ranks 
between 10 and 20. We identified one unknown (rank 13) compound predicted to be aromatic in 
the 10-20 ranks of the random forests list. This unknown compound would be of interest to 
further characterize as a potential novel antimicrobial (Table 2). In our analysis of activity 
against just SA, 3-O-feruloylquinic acid was identified as an additional compound of interest.  
We evaluated the following eight pure compounds that were identified in our initial GC-
MS data overlay for antimicrobial activity alone and in selected combinations at concentrations 
based on GC-MS quantification (in sorbitol equivalents) to assess approximate antimicrobial 
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ratios of the compounds: citric acid, caffeic acid, 3,4-dihydroxybenzaldehyde, 3-O-
caffeoylquinic acid (chlorogenic acid), 4-O-caffeoylquinic acid, 5-O-caffeoylquinic acid, 
kaempferol, and glycolic acid.  We observed a significant reduction (P<0.05) in means relative to 
a positive growth control sample (mean of 0.99 absorbance units, standard error of mean (SE) 
0.08) with caffeic acid at 460 µg/ml (0.62 absorbance units, SE 0.08) with SA 27708. We also 
observed a significant reduction (P<0.05) in means relative to a positive growth control sample 
(0.87 absorbance units, SE 0.05) with MRSA 33593 for 3,4-dihydroxybenzaldehyde at 0.01 
µg/ml (0.70 absorbance units, SE 0.05), glycolic acid at 1 µg/ml (0.66 absorbance units, SE 
0.05), and caffeic acid at both 46 µg/ml (0.73 absorbance units, SE 0.05) and 460 µg/ml (0.72 
absorbance units, SE 0.05). Of our selected combinations of compounds, only the sample 
containing the combination of most components (caffeic acid, citric acid, 3,4-
dihydroxybenzaldehyde, chlorogenic acid, kaempferol, and glycolic acid at 10x concentrations 
listed in Figure 3)  showed antimicrobial activity (0.55 absorbance units, SE 0.05) against 
MRSA, and only against MRSA 33593 (Figure 4).  
Each of the previously-identified compounds were also tested at concentrations of 10 
µg/ml, 20 µg/ml, and 100 µg/ml, although only 3,4-dihydroxybenzaldehyde was observed to 
significantly reduce MRSA growth (from positive control mean of 0.74 absorbance units, SE 
0.03, to 0.66 absorbance units, SE 0.03), and only at 100 µg/ml (Figure 5). Assumptions of 
normality, equal variance, and no block-by-treatment interaction were upheld with the exception 
of SA 113 (Figure 5A), in which a significant block-by-treatment interaction was observed (P < 
0.05), which meant that no conclusion could be drawn from Figure 5A. 
A total of 12 ranked peak lists were produced using statistical tests and classification 
analyses from MetaboAnalyst software and LDA. Among the lists generated by supervised 
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learning (PLS-DA, random forests, LDA), the accuracies were similar, with an accuracy of 0.83 
for both LDA and random forests with the MRSA data, and accuracies of 0.86 for SA LDA and 
0.80 for SA RF. PLS-DA had an accuracy of 0.77 for both MRSA and SA (confusion matrices in 
Table S 6). There was no obvious similarity between misclassified samples, although several 
samples had relatively low intensities. 
The relationship between result lists from different classification methods was assessed 
using a rank biased overlap analysis (Webber et al., 2010) and are summarized in Table 3. The 
lists generated by t-test, SAM, and EBAM were nearly identical (RBO > 0.99 similarity), so only 
the t-test list is displayed in Table 4. PCA, fold-change, and SVM lists were most different from 
each other and other lists (RBO < 0.1). The fold-change list was additionally noted to contain 
many derivitization artifacts with high rank (7 of the top 10 were derivitization artifacts). 
Random forests, PLS-DA, and t-test results were more similar to each other with RBO values 
ranging from 0.2 to 0.6 (RBO similarity scale 0 to 1, 1 = identical). Many of the same 
compounds appeared in the top 10 elements of each list, summarized in Table 4. These 
compounds included citric acid, 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, caffeic acid, 
quinic acid, quercetin, and unknown compounds (retention times and major m/z peaks listed in 
Table 4). 
Contributions of the newly-identified potential antimicrobial compounds quinic acid, 
quercetin, and 5-hydroxy-pipecolic acid were further assessed with a logistic regression analysis 
of a single representative m/z peak for each.  Using m/z peaks 537, 471, and 244 for quinic acid, 
quercetin, and 5-hydroxy-pipecolic acid, respectively, we evaluated the area under receiver 
operating characteristic (ROC) curves for the logistic regression analysis of each compound 
(Table 5). The area under the ROC curve followed the ranked order of the compounds with 
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quinic acid at 0.86, quercetin at 0.78, and 5-hydroxy-pipecolic acid at 0.72. All of these values 
are > 0.50, and so there exists some predictive ability over random chance. 
Additional compounds that could not be identified might also contribute to antimicrobial 
activity.  To gain further information about the highly-ranked unknown compounds, functional 
groups were predicted by GMD decision trees for the fragments detected at each unique retention 
time in the random forests list (Table 6, Table 7). For the 315 unique retention times found in our 
dataset, the major predicted functional groups were carboxylic acid derivatives (228), alpha 
amino acids (106), aromatics (119), and carboxylic acids (292) (Table 5). Of particular interest 
was the unknown compound in the random forests top-10 list, but the GMD decision trees 
predicted it to be a carboxylic acid and a carboxylic acid derivative rather than a functional group 
commonly associated with antibacterial activity. In examining the top-20 list from random 
forests, we found an unknown compound (rank 13) that was predicted to contain an aromatic 
group that would be of interest for further characterization as a potentially novel antimicrobial 
compound (Table 2). 
The reliability of these functional group predictions was based on the “VAR5” cross-
validation assessment of each training model done by the Golm group (Hummel et al., 2010), 
with the resulting functional group predictions having an F-measure threshold of at least 0.65 
based on a precision-recall plot (Hummel et al., 2010). The predicted functional group cross-
validation error was 13.54% for “hydroxy“, 9.65% for “aromatic”, and 3.31% for “phenol” 
groups (Hummel et al., 2010).  
Discussion 
Hyphenated chromatography-mass spectrometry techniques have yielded a number of 
downstream data analysis pipelines (reviewed in Hoffmann and Stoye, 2012), from which we 
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implemented functions from XCMS, MetaboAnalyst, and Python’s Numpy. We obtained GC-
MS data for 60 fractions of aqueous yerba mate extract (including biological duplicates) and 
monitored the data-processing steps of XCMS. Since each fraction had a known bioactivity 
against MRSA, we computationally predicted compounds with significant contribution to the 
grouping, or class, of ‘active’ fractions and then assessed the classification using MICs found in 
the literature, as well as our own set of bioassays using authentic standards.  
In our first bioassay, we aimed to assess the effect of key compounds alone and in 
combination using concentrations that approximated the relative content of compounds that were 
visible using GC-MS. We observed caffeic acid to be inhibitory at 46 µg/ml, which is similar to 
the 62.5 µg/ml previously observed for caffeic acid against SA, but smaller than the minimum 
inhibitory concentration (MIC) of 240 µg/ml reported against MRSA (Luís, Silva, Sousa, Duarte, 
& Domingues, 2014). Citric acid and chlorogenic acid were previously shown to have MICs of 
900 µg/ml (Nagoba, Gandhi, Wadher, Potekar, & Kolhe, 2008) and 500 µg/ml or higher (Alves 
et al., 2013; Luís et al., 2014; Su, Ma, Wen, Wang, & Zhang, 2014) for MRSA, respectively, 
although we did not observe these compounds to inhibit MRSA. We did observe the inhibition of 
MRSA by glycolic acid at 1 µg/ml, which is in the activity range of bacterial antibiotics (Tegos 
& Stermitz, 2002). However, glycolic acid was not found with our peak detection parameters, 
and so was not included in our peak ranking analysis or second bioassay. Kaempferol and 
quercetin were previously observed to be active against MRSA at pharmacologically-relevant 
concentrations of 13 µg/ml (Hazni, Ahmad, Hitotsuyanagi, Takeya, & Choo, 2008) and from 10 
µg/ml to 125 µg/ml (Rodríguez Vaquero, Alberto, & Manca de Nadra, 2007; Su et al., 2014), 
respectively. However, we observed no significant growth inhibition for kaempferol or quercetin 
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against MRSA at these concentrations (Figure 5). This lack of inhibition might result from the 
incomplete solubilization in 1% DMSO and, thus, loss of chemicals during filtration.  
A major challenge of analyzing GC-MS data is dealing with the large number of 
attributes relative to the small number of samples. Data with more attributes than samples are 
easily overfit by nonlinear methods, so linear analysis methods are preferred. Since the purpose 
of the automated analysis was to rank attributes by their contribution to antimicrobial activity, 
we required a method capable of classifying and ranking samples. After a pre-processing step of 
feature detection and correction using XCMS software, we found that LDA was a method that fit 
both of these requirements, which has already been implemented in studies of mass spectral 
analysis (Covington et al., 2013; Santos, Nardini, Cunha, Barbosa, & De Almeida Teixeira, 
2014). MetaboAnalyst software also hosts a set of easily implemented techniques for the 
comparative analysis of mass spectral data that resulted in useful comparisons with LDA. This 
work suggested that LDA did not do well at prioritizing antimicrobial compounds with our data 
since none of the known antimicrobial compounds were ranked in the top-10 list (Table 4). The 
limitations of LDA with highly collinear data could have contributed to its poor rankings, as 
suggested previously (Varmuza, He, & Fang, 2003). Random forests classification implemented 
with MetaboAnalyst did, however, prioritize antimicrobial compounds well, ranking 4 of the 
known antimicrobials in the top-10 list. The superiority of random forests over SVM and LDA in 
a GC-MS classification application was previously observed (Chen et al., 2013). Despite this 
apparent success of MetaboAnalyst’s random forests implementation, it also identified sugars in 
the top-10 list. This occurred in other lists too, as well as did derivization artifacts, or peaks that 
were present in the derivitization blank.   
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The highly-ranked matches to sugar compounds that we observed with multiple methods 
likely resulted from a coincidental correlation of sugar concentration with the yerba mate 
fractions observed to have antimicrobial activity. There are background sugar peaks at many 
unique retention times that could be glycosides attached to the active components we have 
identified, but the data generated did not give enough information to categorize them as 
glycosides or background sugar peaks. It is interesting to note that the presence of sugar has been 
observed to promote the activity of antimicrobial compounds (Allison, Brynildsen, & Collins, 
2011). 
Of the potential anti-MRSA compounds identified by our analysis that we were unable to 
experimentally test, 5-hydroxy-pipecolic acid and 3-O-feruloylquinic acid have strong potential 
for antimicrobial activity as hydroxylated phenolic compounds, even though we did not find any 
literature in which these compounds have been tested against MRSA. Quinic acid is a common 
plant metabolite in the shikimic acid pathway that has been reported to have antimicrobial 
activity against SA at 16 µg/ml, but it was not observed to have activity against MRSA at 
concentrations up to 28 µg/ml (Ozçelik, Kartal, & Orhan, 2011).  
In the top-10 unique retention times predicted by random forests, there were an additional 
two aromatic, phenol, and hydroxyl groups predicted in the MRSA data over the SA data (Table 
6).  This identification suggests that aromatic and hydroxylated groups may play a role in the 
MRSA antimicrobial activity of the active fraction, although further analysis would be required 
to test this hypothesis.  Aromatic compounds have antimicrobial activity dependant on hydroxyl 
groups (reviewed in Saleem et al., 2010)), including derivatives of caffeic acid and 
caffeoylquinics, which have previously been observed to inhibit MRSA (Luís et al., 2014). 
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Conclusion 
The increasing resistance of MRSA to existing antimicrobials demands the development of new 
antimicrobial options. Here we have assembled a pipeline that took advantage of the large 
amounts of data generated by GC-MS by implementing existing GC-MS tools for an automated 
analysis that resulted in a ranked list of compounds likely to contribute to the antimicrobial 
activity of aqueous yerba mate extract against MRSA.  We tested the results of this analysis by 
assaying the antimicrobial activity of pure compounds at a pharmacologically-relevant 
concentration. 3,4-dihydroxybenzaldehyde was the only compound we assayed with activity at a 
concentration of 100 µg/ml or less. We also determined that 5-hydroxy-pipecolic acid, quercetin, 
quinic acid, and one unidentified compound could be possible contributors to yerba mate 
antimicrobial activity against MRSA using LDA and a random forests analysis. The unique 
combination of existing methods and tools used in this study generated prioritized lists of 
compounds likely to contribute to the antimicrobial activity of yerba mate extract, of which citric 
acid, caffeic acid, chlorogenic acid, kaempferol, quercetin were observed to inhibit MRSA in 
previous studies (Fattouch & Caboni, 2007; Hazni et al., 2008; Hirai et al., 2010; Luís et al., 
2014; Nagoba et al., 2008; Su et al., 2014). 5-hydroxy pipecolic acid, 3-O-feruloylquinic acid, 
and the unknown compound ranked 13 from the random forests list would be useful for further 
characterization in order to understand which natural compounds in yerba mate might serve as 
useful antimicrobials against both MRSA and SA. 
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Appendix 
Figures 
 
Figure 3. Overlay of initial yerba mate extract fraction chromatograms. A) The black 
chromatogram corresponds to a yerba mate extract fraction that demonstrated antibacterial 
activity against methicillin-resistant Staphylococcus aureus (MRSA); the red chromatogram 
corresponds to a yerba mate fraction that had no antibacterial activity against MRSA. B) 
Retention times of identified compounds and quantification in sorbitol equivalents were reported.  
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Figure 4. Growth of methicillin-sensitive (SA) and methicillin-resistant Staphylococcus aureus 
(MRSA) in the presence of single or multiple pure compounds at proportions approximated from 
GC-MS quantification. Growth with compounds alone or together was compared to the positive 
growth control (no chemical added) to determine inhibitory activity. Statistically significant 
differences greater (*) or less (**) than control are marked by asterisks. Concentrations follow 
the GC-MS quantification values in Figure 3, but in µg/ml. Growth of A. SA 27708, B. MRSA 
33591, and C. MRSA 33593 are reported at 24 h. 
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Figure 5. Growth of methicillin-sensitive (SA) and methicillin-resistant Staphylococcus aureus 
MRSA) in the presence of pure compounds. At concentrations of 10 µg/ml (chemical_1), 20 
µg/ml (chemical_2) and 100 µg/ml  (chemical_3), growth with compounds was compared to the 
positive growth control (no chemical added) to determine inhibitory activity. Statistically 
significant differences greater (*) or less (**) than control are marked by asterisks. Growth of A. 
SA 113, B. SA 27708, C. MRSA 33591, and D. MRSA 33593 are reported at 48 h. SA113 had a 
significant block by treatment interaction, so no conclusions can be drawn from it. 
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Tables 
  
Table 2. Top 20 unique retention times ranked by antimicrobial significance against MRSA 
using random forests. 
 
Rank Retention 
Time 
(min.) 
Known Active 
Concentration 
(µg/ml) 
Major Ion Peaks Name 
1 11.44 --- 147, 255, 345 Quinic acid 
2 11.18 900 147, 273 Citric acid 
3 12.71 250 219, 396 Caffeic acid 
4 14.92 --- 147, 217, 361 Sucrose 
5 16.41 10 396, 559 Kaempferol 
6 16.82 125 307 Quercetin 
7 10.8 --- 394 Unknown 
8 16.58 500 147, 255, 307, 345 3-O-caffeoylquinic 
acid 
9 18.03 --- 103, 129, 204, 217, 361 , 427 Raffinose 
10 5.61 --- 144, 158 DA 
11 10.58 --- 55, 57, 69, 75, 81, 83, 97, 99, 
123, 204, 217 
Unknown 
12 16.78 --- 193, 255, 257, 324, 372, 489 4-O-caffeoylquinic 
acid 
13 12.58 --- 143 Unknown, predicted 
aromatic 
14 6.23 --- 295 DA 
15 5.11 --- 59, 86, 100, 133, 160, 174, 175, 
221, 223 
DA 
16 14.47 --- _ Unknown 
17 15.28 --- 103, 129, 204, 217, 305, 361 Unknown 
18 16.85 --- 133, 191, 239, 283, 357, 419, 
447 
5-O-caffeoylquinic 
acid 
19 10.07 --- 262 Unknown 
20 11.85 --- 275 DA 
Known active concentrations were obtained from either literature or our bioassays.  
DA  derivitization artifact 
---  no known inhibitory concentration found 
_  no peaks above cut-off
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Table 3. Rank biased overlap comparison of lists. 
Average RBO MRSA 
 PCA 
Fold 
Change 
PLS-DA SAM SVM T-test LDA EBAM RF 
PCA 1 3.08E-11 0.000366 0.000192 0.002276 0.001582 0.000109 0.001605 0.008998 
Fold 
Change 
3.08E-11 1 0.011483 0 0 7.34E-06 0.075296 1.23E-09 0.000891 
PLS-
DA 
0.000366 0.011483 1 0.618936 0.05196 0.612391 0.012616 0.612037 0.136071 
SAM 0.000192 0 0.618936 1 0.002872 0.999874 0.00313 1 0.224733 
SVM 0.002276 0 0.05196 0.002872 1 0.004933 0.04423 0.004054 0.024031 
T-test 0.001582 7.34E-06 0.612391 0.999874 0.004933 1 0.002991 0.999644 0.220768 
LDA 0.000109 0.075296 0.012616 0.00313 0.04423 0.002991 1 0.002995 0.009479 
EBAM 0.001605 1.23E-09 0.612037 1 0.004054 0.999644 0.002995 1 0.220807 
RF 0.008998 0.000891 0.136071 0.224733 0.024031 0.220768 0.009479 0.220807 1 
Average RBO SA 
 PCA 
Fold 
Change 
PLS-DA SAM SVM T-test LDA EBAM RF 
PCA 1 1.59E-12 2.95E-05 1.13E-05 6.17E-09 0.000676 0.000333 0.00068 0.010393 
Fold 
Change 
1.59E-12 1 0.044871 0 0 3.28E-05 0.098322 1.86E-11 0.001522 
PLS-
DA 
2.95E-05 0.044871 1 0.395548 0.28188 0.388904 0.081874 0.388895 0.149397 
SAM 1.13E-05 0 0.395548 1 0.527674 1 0.015228 1 0.186309 
SVM 6.17E-09 0 0.28188 0.527674 1 0.542135 0.051292 0.542135 0.122868 
T-test 0.000676 3.28E-05 0.388904 1 0.542135 1 0.0154 0.999991 0.182801 
LDA 0.000333 0.098322 0.081874 0.015228 0.051292 0.0154 1 0.015403 0.021609 
EBAM 0.00068 1.86E-11 0.388895 1 0.542135 0.999991 0.015403 1 0.182803 
RF 0.010393 0.001522 0.149397 0.186309 0.122868 0.182801 0.021609 0.182803 1 
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Table 3 notes continued 
Values range from 0, dissimilar, to 1, identical. For comparison between MRSA and SA lists, 
rank biased overlap between MRSA RF and SA RF = 0.19; MRSA LDA and SA LDA = 0.057; 
PCA = 1; PLS-DA = 0.399; T-test = 0.518, EBAM = 0.518; SVM = 0; Fold Change = 0.63.  
 
Table 4. Top ten results for each attribute ranking method. (attachment) 
 
Table 5. Classification accuracy of a single major mz peak for each of the 3 identified 
compounds of interest.   
Area under receiver operating characteristics curve 
 MRSA SA 
quinic acid mz 537 0.83 0.86 
quercetin mz 471 0.78 0.78 
5-hydroxy-pipecolic acid mz 
244 0.72 0.68 
Quinic acid, quercetin, and 5-hydroxy-pipecolic acid classification accuracies are reported as the 
area under the curve (AUC) of a receiver operating curve (ROC) for the logistic regression of 
each single m/z peak MRSA or SA. Accuracy ranges from 0 (no samples accurately classified) to 
1 (all samples accurately classified). 
 
Table 6. Predicted functional groups from Golm 
Unique Retention Time 
Counts from MRSA Top 10 SA Top 10 
All Retention 
Times 
Carboxylic Acid Deriv 4 6 228 
Alkene 0 0 3 
Prim Aliph Amine 0 0 3 
Alcohol 4 5 18 
Alpha Aminoacid 0 0 106 
Carbonyl 0 0 1 
Prim Amine 0 0 4 
Aromatic 5 3 119 
Prim Alcohol 1 2 9 
Phenol 2 0 3 
1 2 Diol 3 2 9 
Sec Alcohol 2 3 9 
Phosphoric Acid Deriv 0 0 1 
Carboxylic Acid 7 7 292 
Hydroxy 2 0 10 
Acetal 1 0 3 
Amine 0 0 3 
Summary of predicted functional groups from only the top 10 unique retention times and from 
all 315 unique retention times of the random forests ranked list. 
64 
 
Supporting Information  
Supporting figures 
 
Figure S 1. Heatmaps showing feature detection and retention time correction of GC-MS data.  
A and B correspond to methicillin-resistant Staphylococcus aureus (MRSA) and C and D 
correspond to methicillin-sensitive S. aureus (SA). Blue and red dots are from samples obtained 
at different times that are in need of retention time correction. The A and C heatmaps display 
data points before retention time correction and the B and D heatmaps display data points after 
retention time correction. The complete overlap of blue over red would show perfect retention 
time correction.  
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Supporting tables 
Table S 1. Final parameters implemented with XCMS for feature detection and retention time 
correction of mass spectral data.  
Feature Detection 
XCMS Parameters  Value  Function 
method matchedFilter Feature detection method using a matched filter algorithm 
that compares two classes of spectra to identify features  
snthresh 10 Signal to noise threshold 
max 100 Max peaks selected per mass chromatogram 
step 1.0 Step size between masses (increased to match the unit mz 
resolution of our instrument) 
bin 2 Steps per bin 
mzdiff 1 Minimum difference in mz for peaks with overlapping 
retention times 
Retention Time Correction  
XCMS Parameters  Value  Function 
method peakgroups “well behaved” peak groups are used to calculate retention 
time deviation, which is used for alignment 
missing 2 Allowed missing peakgroups 
extra 2 Allowed extra peakgroups 
smoothing loess Loess smoothing method implemented 
family Gaussian Check for Gaussian fit and symmetry; outlier check 
span 0.20 degree of smoothing for  regression fitting  
group()     Function to group peaks with below parameters 
mzwid 1 Width of overlapping mz slices 
minfrac 1 Minimum fraction of samples for peak group to be in,  in at 
least one sample group 
minsamp 1 Minimum number of samples for peak group to be in  
bw 5 before rtcorr,  
3 after rtcorr 
Bandwidth of Gaussian smoothing kernel 
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Table S 2. Ranking values of top 10 attributes for each ranking method. (attachment) 
 
Table S 3. Antimicrobial activity assays of aqueous yerba mate acetonitrile fractions.  
 
Sample 
numbe
r 
Sample type 
(Supernatant) 
Activity 
SA 27708 MRSA 33591 
A B A B 
1 Water super Active Active Active Active 
2 100% MeOH super Active None Active Active 
3 90% MeOH super Active None None Active 
4 80% MeOH super Active None Active Active 
5 70% MeOH super Active Active Active Active 
6 60% MeOH super Active Active Active Active 
7 50% MeOH super Active Active Active Active 
8 40% MeOH super Active Active Active Active 
9 30% MeOH super Active Active Active Active 
10 20% MeOH super Active None Active Active 
11* Water pellet None None None None 
12 100% MeOH pellet Active Active Active Active 
13 90% MeOH pellet Active None Active Active 
14 80% MeOH pellet Active None None Active 
15 70% MeOH pellet None None None None 
16 60% MeOH pellet None None None None 
17 50% MeOH pellet Active Active None None 
18 40% MeOH pellet None None None None 
19 30% MeOH pellet Active None None None 
20 20% MeOH pellet Active Active None None 
Shaded boxes indicate that not enough extract was obtained to perform bioassays. 
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Table S 4. Antimicrobial activity assays of aqueous yerba mate methanol fractions. 
Sample 
number 
Sample type 
(Supernatant) 
Activity 
SA 27708 MRSA 33591 
A B A B 
1 Water super Active Active Active Active 
2 10% Acetonitrile super Active Active Active Active 
3 20% Acetonitrile super Active Active Active Active 
4 30% Acetonitrile super Active Active Active Active 
5 40% Acetonitrile super Active Active Active Active 
6 50% Acetonitrile super Active Active Active Active 
7 60% Acetonitrile super Active Active Active Active 
8 70% Acetonitrile super None Active Active Active 
9 80% Acetonitrile super None None None None 
10 90% Acetonitrile super None None None None 
11* 100% Acetonitrile super None    
12 Water pellet     
13* 10% Acetonitrile pellet None None   
14 20% Acetonitrile pellet None None   
15 30% Acetonitrile pellet None None None None 
16 40% Acetonitrile pellet None None None None 
17 50% Acetonitrile pellet None None None None 
18 60% Acetonitrile pellet None None None None 
19 70% Acetonitrile pellet None None Active None 
20 80% Acetonitrile pellet Active Active Active Active 
21 90% Acetonitrile pellet Active Active Active Active 
22 100% Acetonitrile pellet Active Active None None 
 Shaded boxes indicate that not enough extract was obtained to perform bioassays. 
A and B are replicates. 
Any size zone of inhibition was considered active. 
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Table S 5. Summary of compounds identified as potential antibacterials from GC-MS data and 
MIC concentrations against methicillin-sensitive Staphylococcus aureus (SA) and methicillin-
resistant S. aureus (MRSA) from literature. 
 
Compound SA MIC MRSA MIC References 
Caffeic acid 62.5 ug/ml 250 ug/ml LuÍs et al. 2013 
Citric acid not found 900 ug/ml; 
0.05-0.2 gm% 
Nagoba et al. 1998; 
Thool et al. 2014 
Chlorogenic acid 200 ug/ml; 
500 ug/ml 
 
500 ug/ml 
Zhu et al. 2004; 
LuÍs et al. 2013 
Kaempferol not found 10 ug/ml; 
MIC50 = 13 ug/ml 
Fattouch et al. 2007; 
Hazni et al. 2008 
Quercetin 10 ug/ml 50uM; 
125 ug/ml 
Hirai et al. 2010; 
Su et al. 2014 
Quinic acid 16 ug/ml >28 ug/ml Özçelik et al. 2011 
   
 
Table S 6. Accuracies of classification methods shown in confusion matrices. 
 
 MRSA      SA    
 
LDA 
Predicted  
RF 
Predicted  
 
  
LDA 
Predicted  
RF 
Predicted  
 -1       1  -1 1   -1       1  -1 1 
-1 11     4 -1 9 6  -1 8     10 -1 11 7 
1 6     39 1 4   41  1 5     37 1 5 37 
           
 
PLS-DA 
accuracy     PLS-DA accuracy   
 0.77      0.77    
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Table S 7. Predicted functional groups listed for the top 10 compounds with retention time (RT), 
retention index (RI) and name if known. 
Rank RT RI Name Predicted Functional 
Groups 
A. MRSA 
1 11.43 1983.451 quinic acid 
Carboxylic Acid, 
Alcohol, 
Carboxylic Acid Deriv., 
Aromatic 
2 11.18 1930.634 citric acid 
Sec Alcohol, 
Carboxylic Acid, 
Alcohol, 
Carboxylic Acid Deriv. 
3 12.72 2254.577 caffeic acid 
Hydroxy, 
Aromatic, 
Carboxylic Acid, Phenol, 
Carboxylic Acid Deriv. 
4 14.92 2719.366 sucrose None 
5 16.42 3036.268 kaempferol Carboxylic Acid, 
Aromatic 
6 
16.82 3120.775 quercetin 
1 2 Diol, 
Carboxylic Acid, 
Aromatic 
7 10.8 1849.648 unknown Carboxylic Acid, 
Carboxylic Acid Deriv. 
8 
16.58 3071.479 
3-O-
caffeoylquinic 
Carboxylic Acid, 
Hydroxy Aromatic, 
1 2 Diol, 
Phenol Alcohol 
9 
18.03 3377.817 raffinose 
1 2 Diol 
Sec Alcohol, 
Acetal, 
Alcohol, 
Prim Alcohol 
10 5.62 754.5775 derivitization 
artifact 
none 
B. SA 
1 11.18 1930.634 citric acid 
Sec Alcohol, 
Carboxylic Acid, 
Alcohol, 
Carboxylic Acid Deriv. 
2 11.43 1983.451 quinic acid 
Carboxylic Acid, 
Alcohol, 
Carboxylic Acid Deriv., 
Aromatic 
3 10.67 1821.479 unknown Carboxylic Acid, 
Carboxylic Acid Deriv. 
4 13.78 2479.93 unknown 
Carboxylic Acid, 
Carboxylic Acid Deriv., 
Aromatic 
5 11.85 2071.479 derivitization 
artifact 
Carboxylic Acid, 
Aromatic 
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Table S 7 continued 
Rank RT RI Name Predicted Functional 
Groups 
6 
10.52 1789.789 unknown 
Carboxylic Acid, 
Alcohol, 
Carboxylic Acid Deriv 
 
7 
10.35 1754.577 unknown 
1 2 Diol 
Sec Alcohol, 
Alcohol, 
Prim Alcohol, 
8 
16.5 3053.873 
3-O-
caffeoylquinic 
Carboxylic Acid, 
Aromatic, 
9 10.32 1747.535 
unknown 
Carboxylic Acid, 
Carboxylic Acid Deriv. 
10 
10.58 1803.873 unknown 
Sec Alcohol, 
Alcohol, 
1 2 Diol 
Prim Alcohol 
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CHAPTER IV 
METABOLITES ACCUMULATED DURING SALMONELLA ENTERICA 
SEROVAR TYPHIMURIUM AND LACTOBACILLUS CASEI YERBA 
MATE TREATMENT AND THE RESCUING EFFECT OF EXOGENOUS 
IRON SULFATE ON S. TYPHIMURIUM 
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This manuscript reports on a learning experience that will remain unpublished. 
 
CS Rempe led this project based on previous work by KP Burris, designed the experiments, and 
carried out all experiments aside from the initial Salmonella Typhimurium growth experiments, 
which were done by K Higgenbotham and KP Burris. TJ Tschaplinski assisted with the 
metabolomics experimental design and analysis. KP Burris and CN Stewart, Jr. assisted with the 
development and direction of the project. 
Abstract 
Plant extracts are a potential source of novel antimicrobials that could kill both pathogenic and 
probiotic bacteria. This study assessed the in vitro effect of aqueous yerba mate extract on the 
growth of Salmonella enterica serovar Typhimurium and three Lactobacillus strains. S. 
Typhimurium was significantly inhibited at 64 mg/ml aqueous yerba mate extract while a 
biologically insignificant effect of < 3 log fluctuation in growth was observed in the 
Lactobacillus strains. An untargeted metabolomics approach was used to further investigate S. 
Typhimurium and L. casei in vitro growth alone or in the presence of yerba mate extract in order 
to monitor any decreases in yerba mate phenolic compounds from culture supernatants that could 
signify bacterial metabolism. A gas chromatography – mass spectrometry analysis of derivitized 
cell culture extracts was used to monitor the accumulation of metabolites in L. casei and in S. 
Typhimurium with starting inoculums that were not susceptible to the antibacterial effects of 
yerba mate extract.  In both S. Typhimurium and L. casei the major metabolites that accumulated 
differently between treatments were sugars present in the yerba mate extract and common 
constituents of citric acid metabolism. The differences in oxalomalate when S. Typhimurium was 
grown with or without yerba mate led to the hypothesis that yerba mate impacts iron 
homeostasis, which was tested by supplementing cultures of S. Typhimurium and an inhibitory 
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concentration of yerba mate extract with iron sulfate. The partial recovery of S. Typhimurium 
with exogenous iron sulfate suggests that disruption of iron, sulfate, or the stability of iron-
sulfate clusters is involved in the antibacterial activity of yerba mate extract against S. 
Typhimurium. 
Introduction 
Plants produce a complex mixture of biologically active chemicals from which herbal medicines, 
modern drugs, antimicrobials, and pesticides have been developed. Phenolic compounds are 
abundant in plants and plant-derived food products. When ingested, phenolic compounds are not 
readily available to the human system, but they do encounter microbes in the gut that have the 
opportunity to metabolize phenolic compounds into derivative molecules (reviewed by de Souza 
et al. 2015) that may or may not exert an effect on other microbes or on the human system. 
Phenolic plant extracts are known to inhibit a broad range of bacterial enteropathogens (reviewed 
by Cowan, 1999), yet they stimulated the growth of Lactobacillus acidophilus (Hervert-
Hernández, Pintado, Rotger, & Goñi, 2009) and had no effect on several indigenous gut bacteria 
(Lee, Jenner, Low, & Lee, 2006). The ability to target bacterial pathogens and bypass other 
bacterial strains could reduce or prevent the rise of diarrhea-causing pathobionts like Clostridium 
difficile, which thrive when normal gut-microbe populations are reduced in size and diversity by 
antibiotics (briefly reviewed by Cervantes, 2016). A better understanding of microbial 
metabolism of phenolic compounds is needed in order to assess health benefits or risks of 
consuming certain phenolic sources. Furthermore, a deeper understanding of the mechanisms 
behind inhibition or stimulation of phenolic compounds could reveal new means of treating 
bacterial pathogens with resistance to common antibiotics.  
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Yerba mate is a traditional South American beverage made from aqueous extracts of a plant 
known by the same name (Ilex paraguariensis; family Aquifoleaceae). Yerba mate extracts have 
antimicrobial activity against a wide range of foodborne bacterial pathogens (Burris et al., 2011, 
2012), including the globally relevant enteropathogen, Salmonella enterica serovar 
Typhimurium. S. Typhimurium contributes to thousands of infections and about 30 deaths 
annually in the U.S. S. Typhimurium strains, including the definitive phage type (DT) 104 strain 
2576 used in this study, are also known to be resistant to several antibiotic drugs (CDC, 2013; S. 
M. Crim et al., 2014; Scallan et al., 2011).  Yerba mate has a high phenolic content and shares 
compounds with grape pomace and tea extracts that have been previously observed to stimulate 
Lactobacillus acidophilus or leave native gut strains unaffected (Heck & de Mejia, 2007; 
Hervert-Hernández et al., 2009; Lee et al., 2006). Lactobacillus strains have also been noted to 
metabolize phenolic compounds (Filannino et al., 2015; Rodríguez et al., 2008; Sánchez-
Maldonado et al., 2011). The degradation of aromatic compounds and their breakdown 
metabolites were previously observed for several gut bacteria, including Lactobacillus casei and 
Salmonella enteridis (Lee et al., 2006). Though S. Typhimurium DT104 has been observed to be 
strongly inhibited by phenolic compounds (Lee et al., 2006), it is predicted to contain some 
enzymes capable of acting on aromatic compounds, including a salicylate hydroxylase, flavin 
reductase, and alcohol dehydrogenase (KEGG database). 
While many studies have examined the impact of antimicrobial plant extracts on 
probiotics, we have not encountered any metabolomic analyses of S. Typhimurium or L. casei 
growth in the presence of yerba mate extract prior to this dissertation. The aims of this study 
were to 1) determine the growth effects of different concentrations of yerba mate extract on the 
foodborne pathogen S. Typhimurium and 3 Lactobacillus strains and 2) identify any phenolic 
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compounds that decreased over time from the supernatants of S. Typhimurium or L. casei during 
growth with yerba mate extract. Since no identifiable phenolic compounds were observed to 
significantly decrease over time, the limitations of this experimental design were used to improve 
the experimental plan for the final chapter of this dissertation. Despite the lack of identifiable 
phenolic compounds, oxalomalate was a non-phenolic compound that accumulated when S. 
Typhimurium was grown with yerba mate extract. The accumulation of oxalomalate, which is 
known to interfere with iron-sulfur clusters of aconitase (Ruffo, Testa, Adinolfi, & Pelizza, 
1962), combined with knowledge that phenolics tend to chelate metals, motivated the testing of 
iron chelation as a mode of action of yerba mate extract. 
Materials and methods 
 Yerba mate aqueous extraction 
A commercial brand of yerba mate tea (Taragui; 100% leaves, Argentina), was purchased from a 
local international supermarket (Knoxville, Tenn, USA) and ground with an Oster blender (Boca 
Raton, Fl. USA) to a particle size of <1 mm. The ground tea was then extracted in ten times its 
mass of water at 4 °C for 3.5 h, 0.45 µm vacuum filtered, frozen at -80 °C, and lyophilized using 
a FreeZone, 12 L freeze dryer (Labconco, Kansas City, Mo. USA). Dried extracts were stored at 
room temperature in a sealed container until testing.   
Phenolic content determination 
Phenolic content of the extract was determined using Folin-Ciocalteu’s phenol reagent 
(Montreau, 1972). Extracts were resuspended in water (1 mg/ml) and filtered through Whatman 
No. 4. The phenolic content was quantified using gallic acid as the standard and expressed in mg 
gallic acid equivalents (GAE)/g dry tea extract after the absorbance was read at 765 nm. 
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Bacterial culture maintenance 
L. bulgaricus ATCC 11842 was purchased from the American Type Culture Collection (ATCC; 
Manassas, Va., USA), L. acidophilus (LA-5) and L. casei 431 were generously donated by Chr. 
Hansen (Milwaukee, Wi. USA), and S. Typhimurium DT104 strain 2576 was obtained from the 
Department of Food Science and Technology at the University of Tennessee. Stock cultures of L. 
bulgaricus and S. Typhimurium strains were stored in glycerol at -20 °C. L. casei and L. 
acidophilus were received and stored at -80 °C as frozen pellets. Cultures were maintained by re-
inoculation in ultra-high temperature (UHT) nonfat skim milk (<0.05% fat; Diversified Foods, 
Inc., Metairie, LA, USA) or nutrient broth daily and starting new cultures from frozen stocks 
weekly. Prior to subculturing and growth experiments UHT milk was centrifuged at 5,000 × g 
for 30 min at 4 °C, then sterilely decanted into 50 ml tubes for storage at 4 °C. 
Bacterial growth experiments 
Yerba mate extracts were reconstituted in MilliQ water and syringe filtered through 0.22 µm 
Express PES Membrane (Millipore, Billerica, Ma., USA) prior to microbial susceptibility testing.  
All growth experiments were performed in 125 ml flasks containing 12.5 ml UHT milk, 10 ml 
reconstituted yerba mate extract or water, and 2.5 ml dilute bacteria ca. 5-6 log CFU/ml or UHT 
milk (Lactobacillus strains) or sterile 0.1% peptone (S. Typhimurium) for a total volume of 25 
ml. We observed that the Lactobacillus strains grew much faster in milk than in other media, so 
all our experiments (including S. Typhimurium experiments) were conducted in milk to optimize 
growth time. Experiments were conducted at 37 °C for L. casei, L. bulgaricus, and S. 
Typhimurium and at 40 °C for L. acidophilus. Controls were prepared similarly using milk or 
water in place of bacteria (negative) or extract (positive) respectively. 
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Initial growth experiments performed with S. Typhimurium, L. acidophilus, and L. casei 
were all assessed at concentrations of 0, 0.4, 2, 4, 8, 16, 32, and 64 mg/ml yerba mate extract 
with time points at 0, 10, 24, and 48 h. L. casei was additionally monitored at 72 h since growth 
was slower. L. bulgaricus was monitored only at the concentrations deemed most relevant from 
previous experiments (0, 32, and 64 mg/ml for 0, 10, 24, 48, and 72 h). For metabolomics 
experiments, starting cultures were diluted to ca. 6-7 log CFU/ml and samples were only taken at 
0 h and 48 h in a triplicate experiment with treatments of bacteria + yerba mate extract, only 
bacteria, and only yerba mate extract. For iron supplementation experiments, samples were taken 
at 0, 10, 24, and 48 h. 
At each time point, a sample from each flask was serially diluted in 0.1% sterile peptone 
and pour-plated in duplicate using de Man, Rogosa, and Sharpe (MRS) or tryptic soy agar 
(TSA). Lactobacillus plates were grown anaerobically using AnaeroGen (Oxoid, Cambridge, 
UK) packets in airtight containers at 37 °C for 3 d. S. Typhimurium plates were grown 
aerobically at 37 °C for 24 h. Following incubation, colony forming units were enumerated. The 
pH was additionally monitored for Lactobacillus strains with 1 ml samples taken at each time 
point and measured in duplicate with an UltraBasic UB-10 pH meter (Denver Instruments, 
Bohemia, NY., USA). 
Metabolomics 
A 100 µl sample was taken from each treatment flask at each time point, quenched in 900 µl 
80% methanol, vortexed, centrifuged at 20,000 × g for 5 min., and then the supernatant was 
collected. This was repeated with the pellet in 900 µl DI water to lyse cells, then in another 900 
µl 80% methanol for a final extracted volume of 2700 µl in methanol and water that was stored 
at -20 °C in glass tubes. Plastic microcentrifuge tubes were used for initial extraction, so all 
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samples should have been equally contaminated with extracted plastic components.  50 µl of 
each extract and 10 µl of 0.1000 g/100 ml gallic acid (internal standard) were transferred to 
scintillation vials and dried under sterile flowing nitrogen. Each sample was then trimethylsilyl 
derivitized with 500 µl acetonitrile and 500 µl MSTFA at 70 °C for 1 hour. After 3 days 
(Lactobacillus) or 2 days (S. Typhimurium) an autosampler was used to inject samples into a 
GC-MS instrument (Agilent Technologies Inc., Santa Clara, Calif., USA) with a 5975C inert XL 
gas chromatograph-mass spectrometer, fitted with an Rtx-5MS with Integra-guard (5% 
diphenyl/95% dimethyl polysiloxane) capillary column 30 m by 250 µm by 0.25 µm of film 
thickness). This standard quadrupole GC-MS instrument was operated as was detailed in Rempe 
and Burris et al. 2015, with electron impact (EI) ionization at 70 eV, six 50 Da to 650 Da scans 
per second, and helium gas flow rate of 1.33 ml/min with the injection port in splitless mode. 
Temperatures were kept at 250 °C for the injection port, 230 °C for the mass spectrometer 
source, and 150 °C for the mass spectrometer quad. The oven was programmed to start at 50 °C 
for 2 min, ramp up to 325 °C at 20 °C per min, hold for 11 min, and then cycle back down to 50 
°C.  
Data analysis 
Initial growth experiments were each set up and analyzed as a randomized block design, blocked 
on replicate with sampling in duplicate.  Treatment design was repeated measures with 
concentration applied to each flask and time applied within each flask. Experiments were 
replicated three times.  Bacterial growth data were analyzed by analysis of variance (ANOVA) 
using mixed models (SAS 9.3, SAS Institute, Cary, N.C., USA). Least significant differences 
(LSD) were used to compare treatment mean values when significant differences (P<0.05) were 
found. Error bars in preliminary growth data represent the standard error of the mean across both 
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concentration and time using LSD.  Error bars in iron supplemented growth data represent 
standard deviations of triplicate experiments. 
Metabolomic data was normalized to the gallic acid internal standard, then XCMS 
software (C. A. Smith et al., 2006) was used for peak selection and retention time correction with 
parameters based on the GC-MS default settings from XCMS Online (Tautenhahn & Patti, 
2012).  
 To investigate treatment and time differences, the unscaled data matrix was analyzed as 
a randomized block design, blocked on replicate, with split plots since only two time points (0 h 
and 48 h) were sampled within each flask. The three flask treatments were bacteria and yerba 
mate extract, bacteria only, and yerba mate extract only. ANOVA assumptions were tested in R 
with the Levene test for equal variance (P>0.05) and the Shapiro-Wilks test for normality 
(W>0.80). If these assumptions were not met, means were compared with the non-parametric 
Kruskal-Wallis test, otherwise data were analyzed using linear mixed models (package nlme, R 
Foundation for Statistical Computing, Vienna, Austria). P-values illustrating differences in 
treatment means, time point means, and interactions between treatment and time point means 
were adjusted for multiple comparisons (false discovery rate 0.05, R function p.adjust) and used 
to sort metabolite ions. The Wiley GC-MS library and an in-house library were used to attempt 
to identify the compounds containing ions with significant main effects of time and treatment, or 
significant main effects of either time or treatment and a significant interaction between time and 
treatment (adjusted P<0.05). 
Iron assays 
Fe
2+ 
and Fe
3+
 were obtained from iron sulfate heptahydrate and iron chloride, respectively. New, 
unused plasticware and autoclaved milliQ water were used for chemical assessments of yerba 
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mate iron chelation. Reactions were done in 96-well plates with 250 µl total volumes. Dilutions 
of 0.22 µm filtered yerba mate extract were made from a fresh 160 mg/ml stock solution and 
FeSO4 solutions were made by diluting a fresh 100 mM stock solution. A 100 mM FeCl3 
solution was kept at 4 ⁰C and used for all Fe3+ assays since FeCl3 is stable in solution. 
Chlorogenic acid and EDTA were diluted to 1 mM from 100 mM stock solutions and then added 
for a final concentration of 0.1 mM. Yerba mate extract was added at final concentrations of 0.32 
mg/ml (“high”) and 0.16 mg/ml (“low”) in saturation assays and in competition assays before the 
addition of ferrozine. Milk was added at 12 µl milk per ml final volume in saturation assays and 
in competition assays (not including volume of ferrozine). Competition assays tested the ability 
of ferrozine to compete with the tested chemicals for iron binding. The tested chemicals were 
added to the well first (100 µl), then FeSO4 or FeCl3  (25 µl), and then ferrozine (12.5 µl) or 
water (12.5 µl; control) was added last. Absorbance was monitored at 562 nm (absorbance peak 
of ferrozine-Fe
2+
 complex) one hour after the addition of ferrozine. Since the binding of 
phenolics to iron is visible with UV-vis spectroscopy, saturation assays were done to tentatively 
observe where the iron-phenolic complex becomes saturated (100 µl dilute test compound + 25 
µl dilute iron solution). No ferrozine was used in these assays and only phenolic chemicals were 
tested since others do not have a visible absorbance shift with iron binding. Absorbance at 380 
nm, where a slight increase in absorbance was observed with increasing concentrations of iron 
(Figure S 2), was recorded after one hour. 
 Growth assays of S. Typhimurium were supplemented with FeSO4 added at 
concentrations of 0, 3.2, and 9.6 mM FeSO4 based on putative saturation regions observed in the 
chemical iron binding assessments at 0.1, 1, and 3 mM FeSO4 (Figure S 3). 25 ml total volume 
flasks were used with tea in final concentrations of 32 mg/ml or 64 mg/ml and iron in final 
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concentrations of 0, 3.2, and 9.6 mM FeSO4. The tea and iron solutions were solvated with pH 
5.5 phosphate buffer and adjusted to pH 5.5 before 0.22 µm syringe filtering and subsequent 
addition of sterile milk and dilute overnight culture (ca. 5-6 log CFU/ml). Flasks were not acid-
washed, so trace amounts of iron likely contributed to experimental error. Data was analyzed to 
compare buffered and unbuffered samples without iron in random block design blocked on 
replicate with buffer vs. water treatments using repeated measures with time (0, 10, 24, 48 h) and 
subsampling. Iron supplemented growth data was analyzed at each time point separately using a 
random block design blocked on replicate with iron (0, 3.2, 9.6 mM FeSO4) and tea treatments 
(0, 32, 64 mg/ml extract).  
Results 
Extract and phenolic content 
For every 10 g of ground tea, approximately 2.2 g of freeze dried extract was obtained. This 
means our initial cold water extract concentration was about 22 mg/ml of the final lyophilized 
extract. The lyophilized extract was easily resuspended in water.  The highest concentration of 
extract (64 mg/ml) in milk had an average starting pH of 5.5, and the phenolic content was 
determined to be ca. 81 ± 3.4 mg GAE/g freeze-dried extract. 
Bacterial growth with yerba mate extract 
Our data demonstrated that a 64 mg/ml aqueous extract of yerba mate was capable of in vitro 
inactivation of S. Typhimurium in milk by 48 h (Figure 6A) while minimally affecting the 
growth of L. casei, L. acidophilus, and L. bulgaricus (Figure 6B, C, and D, respectively).  S. 
Typhimurium growth was significantly reduced by ca. > 5 log CFU/ml at 64 mg/ml by 48 h 
while we observed fluctuations of < 3 log CFU/ml in the growth of L. casei, L. acidophilus, and 
L. bulgaricus relative to their controls (Figure 6).  
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Metabolomics 
Using adjusted p-values from the ANOVA model, 22 S. Typhimurium metabolites (11 
tentatively identified) and 46 L. casei metabolites (16 tentatively identified) were found to be 
significantly different across treatment or time. The compounds with significantly different 
treatment means, time means, and/or interaction between treatment and time are listed in Table 7 
(L. casei) and Table 8 (S. Typhimurium). The identifiable compounds with significantly altered 
accumulation patterns between treatment and/or time groups tended to be either sugars consumed 
from the yerba mate extract or compounds involved in common metabolic pathways, including 
the citric acid cycle. The only putatively identified phenolic compound was sinapyl alcohol in 
the L. casei supernatant, but it accumulated in the bacteria treatments both with and without 
yerba mate extract.  
Iron binding assays 
Using ferrozine to monitor Fe
2+
, the expected linear relationship was observed between 562 nm 
absorbance (ferrozine-Fe
2+
 complex) and the concentration of added FeSO4 in water. This linear 
relationship was clearly seen with water, chlorogenic acid, and tea samples, indicating they did 
not effectively compete with ferrozine to bind Fe
2+ 
(Figure 7A). The EDTA control and all the 
samples containing milk showed a delayed absorbance as EDTA or milk bound to Fe
2+
 and 
removed it from ferrozine (Figure 7A). At about 0.5 mM FeSO4, though, there was sufficient 
iron to interact with ferrozine and a linear relationship between absorbance (Fe
2+
 complex 
formation) and iron concentration was observed from that point (Figure 7A). 
There was no signal with added FeCl3 in water, with EDTA, or with milk, as expected 
since FeCl3 supplies Fe
3+
 which cannot interact with ferrozine (Figure 7C). Chlorogenic acid and 
all the samples containing tea did show a delayed absorbance though, indicating that they are 
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capable of converting Fe
3+
 to Fe
2+ 
(Figure 7C). Controls without ferrozine showed no observable 
interference at 562 nm (Figure 7A, Figure 7D). 
In saturation assays the native absorbance was monitored at 380 nm, a wavelength where 
absorbance was observed to vary between yerba mate extracts with high and low iron 
concentrations (Figure S 2). The tea and milk trends showed very little difference with both 
FeCl3 and FeSO4. When tea and milk were combined in growth assay proportions, a clear curve 
was visible with the absorbance signal showing theorized iron saturation at about 1-1.5 mM Fe 
(Figure S 3).   
Bacterial growth with iron supplementation 
S. Typhimurium with 32 mg/ml tea extract grew at all concentrations of added iron with no 
significant difference at 48 h. With 64 mg/ml, S. Typhimurium was killed by 48 h in the 
treatments with 0 mM FeSO4  (differed from all other treatments with P<0.05), but survived with 
a mean of 7.5 log CFU/ml when supplemented with 9.6 mM FeSO4, which was not significantly 
different from the ca. 8.5 log CFU/ml means of the 0 and 32 mg/ml tea treatments with and 
without iron at 48 h (Figure 8). The treatment with 64 mg/ml tea and 3.2 mM iron grew with a 
mean of ca. 4.5 log CFU/ml at 48 h, which was significantly different from all the other 
treatments at 48 h (P < 0.05).  
Discussion 
A 64 mg/ml concentration of the aqueous extract of yerba mate significantly inhibited the growth 
of S. Typhimurium but did not have a major effect on the growth of L. casei, L. acidophilus, or 
L. bulgaricus in vitro. Although 64 mg/ml is higher than the 14.6 mg/ml previously observed to 
inhibit S. Typhimurium in tryptic soy broth (TSB) (Gonzalez-gil et al., 2014), growth in milk 
rather than TSB has been observed to reduce S. Typhimurium susceptibility to antibiotics 
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(Branen & Davidson, 2004). 64 mg/ml is also greater than the original cold water extract we 
obtained, which was 22 mg/ml. 22 mg/ml might be comparable to a commonly ingested 
concentration of yerba mate since a range of 21.7-34.5 mg/ml was obtained from aqueous yerba 
mate leaf extracts in another study (Sambiassi, Escalada, & Schmalko, 2002), or higher than an 
ingested concentration since the “soluble solids” obtained from yet another set of hot and cold 
water extractions ranged from 4.8-7.8 mg/ml (Bastos, Fornari, De Queiroz, Soares, & Torres, 
2005). 
Yerba mate extract is rich in phenolic compounds (Heck & de Mejia, 2007); this 
evaluation found ca. 81 ± 3.4 mg GAE/g dry extract, comparable to the 110.5 ± 14.3 mg GAE/g  
observed previously (Deladino et al., 2013). Since phenolics are known to have antibacterial 
properties, GC-MS with TMS-derivitized samples was used to profile any changes in phenolic 
compounds and common bacterial metabolites.  
The first goal of this metabolomics analysis was to assess whether any phenolic 
compounds present in the tea extract were metabolized by the bacteria. Although the changes in 
L. casei growth patterns were not biologically meaningful, they were statistically significant 
(P<0.05) and showed a growth lag between 10 h and 24 h in comparison to controls. This trend 
could be explained by a particular compound in the extract initially inhibiting growth, but then 
later being degraded or utilized by L. casei. However, we did not observe any identifiable 
phenolic compounds with a significant change between 0 h and 48 h except for sinapyl alcohol, 
which appeared to be produced by L. casei or be a breakdown product of milk components. 
Either way, the changes in this compound putatively identified as sinapyl alcohol were 
independent of yerba mate extract. Most of the compounds observed to decrease over time in the 
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tea samples were sugars with both L. casei and S. Typhimurium, which were likely metabolized 
as carbon sources.  
Since there were no identifiable phenolic compounds with significant changes across 
time and yerba mate treatment, the S. Typhimurium pathways altered by yerba mate extract were 
further investigated in literature searching in order to create hypotheses about yerba mate’s 
antibacterial mechanism(s). The metabolomics analysis revealed a significant difference in 
oxalomalate between S. Typhimurium treatments, so it was investigated further and found to 
compete with iron-sulfur clusters for binding to eukaryotic aconitase, which is structurally very 
similar to aconitase A of Salmonella, and to bacterial isocitrate lyase (Baothman, Rolfe, & 
Green, 2013; Walden, Selezneva, & Dupuy, 2006). Oxalomalate is often formed non-
enzymatically by the interaction of oxaloacetate and glyoxylate. It is not clear whether the 
oxalomalate observed was produced non-enzymatically or enzymatically by the bacteria.  
Since phenolic components of yerba mate extract are already known to have a strong 
ability to chelate metal ions, including iron (Guo et al., 2007; Kono & Kashine, 1998), we 
decided to test the hypothesis that the yerba mate extract chelates iron and so starves S. 
Typhimurium of this necessary element. This hypothesis was also in accord with our observation 
that 3 Lactobacillus strains are generally unaffected by yerba mate extract since Lactobacilli use 
manganese rather than iron and they lower the pH of their environment to levels that generally 
deter the chelation of any metal ions (Imbert & Blondeau, 1998). However, metabolic signs of 
iron stress through increased amounts of enterobactin and pyruvic acid (Reissbrodt et al., 1997), 
were not apparent since neither of these compounds were identifiable in the GC-MS spectra. 
 In order to probe the relationship of iron to our antibacterial tea system, the iron binding 
capabilities of yerba mate extract were assayed, followed by EDTA, chlorogenic acid, milk, and 
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combinations of tea and milk (Figure 7). It is clear that the milk alone and the milk and tea 
combination are capable of binding Fe
2+
 from the ferrozine competition assay, which we 
expected since milk contains the iron storage protein lactoferrin. However, the ferrozine assay 
did not show any binding capabilities of chlorogenic acid or yerba mate extract. Chlorogenic 
acid has been previously observed to chelate iron in 1:1 and  3:1 ratios, with visible UV-vis 
absorbance shifts at 324 nm and 355 nm (Kono & Kashine, 1998).  Yerba mate was observed to 
have shifts at 320 nm and 380 nm that could be representative of single phenolics depleting and 
an iron-phenolic complex forming (Figure S 2). With this observation and claims of yerba mate 
iron chelation in the literature (Huang et al., 2014; Salkić & Ćavar Zeljković, 2014), it is possible 
that ferrozine is able to bind more strongly to Fe
2+
 than either chlorogenic acid or any of the 
yerba mate phenolics. By further monitoring the native absorbance shift of both the tea and 
chlorogenic acid at 380 nm, saturation curves were observed that could be interpreted as the 
formation of an iron-phenolic complex (Figure S 3). Using the proportions of iron to tea found 
where the saturation curve plateaued, we selected two iron concentrations that might provide 
enough uncomplexed iron for the bacteria to survive low iron stress. These concentrations were 
close to the start of the plateau since bacteria generally require only 10
-7
 to 10
-5
 M iron for 
optimal growth (Andrews, Robinson, & Rodríguez-Quiñones, 2003). 
The supplementation of FeSO4 at 9.6 mM clearly rescued S. Typhimurium from the 
antibiotic effects of 64 mg/ml yerba mate extract, although growth was still significantly below 
the level of the treatments with no tea and the 32 mg/ml tea. This supports the hypothesis that the 
iron chelation of yerba mate extract plays a major role in its antibacterial function. Although 
many other studies hypothesize iron as a potential factor in the antimicrobial activity of phenolic 
plant extracts, to our knowledge we are the first to test it with a whole plant extract. A similar 
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assay with tannic acid found that exogenous iron prompted the recovery of bacterial pathogens 
(Chung et al., 1998). A possibility remains that milk components acted synergistically with 
phenolics to withhold iron since direct evidence of yerba mate binding to iron was not observed. 
Future experiments are needed to assess whether a major portion of yerba mate extract’s 
antibacterial activity against S. Typhimurium is simply from chelating iron or if a more complex 
mechanism is at work. 
Conclusion 
The effects of yerba mate extract on the growth of three Lactobacillus strains and the pathogen S. 
Typhimurium was evaluated, the metabolic effects of yerba mate extract on L. casei and S. 
Typhimurium was surveyed, and finally the hypothesis that iron is involved in the antibacterial 
effect of yerba mate extract against S. Typhimurium was tested. It was found that the addition of 
ferrous iron sulfate rescued S. Typhimurium from the antibacterial effect of yerba mate extract. 
Additional experiments are needed to assess whether it was chelation of iron by yerba mate or a 
different mechanism that is the main source of the antibacterial effect, but this study has verified 
that iron has an influence. 
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Appendix 
Figures  
 
Figure 6. Growth trends (log CFU/ml) of A. S. Typhimurium, B. L. acidophilus, C. L. casei, and 
D. L. bulgaricus in UHT skim milk at different concentrations of yerba mate extract. Error bars 
represent ± 1 standard deviation (triplicate experiment). 
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Figure 7. Plots show competition assays of ferrozine; A. Fe
2+
 (FeSO4) and C. Fe
3+
 (FeCl3) were 
tested and controls without ferrozine were also tested with B. Fe
2+
 and D. Fe
3+
. Experiments 
were done at least in duplicate. Error bars represent standard deviation. Tea concentrations were 
0.32 mg/ml (“high”) and 0.16 mg/ml (“low). 
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Figure 8.  Growth of S. Typhimurium in 3 concentrations of iron (FeSO4) and 2 concentrations of yerba mate extract (“tea”) is plotted 
over time. Error bars show standard deviation for 3 replicates with the exception of the 10 h time point, which only had 2 replicates. 
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Tables 
Table 7.  L. casei metabolites found to be significantly different between treatments with 
‘control_no_bacteria’ = milk+tea, ‘control_no_tea’ = milk+bacteria, and ‘tea’ = 
milk+tea+bacteria. Extracted ion intensity values normalized to a gallic acid internal standard are 
listed with data ranges in parentheses. (attached) 
Table 8. S. Typhimurium metabolites found to be significantly different between treatments with 
‘control_no_bacteria= milk+tea, ‘control_no_tea ’ = milk+bacteria, and ‘tea’ = 
milk+tea+bacteria. Extracted ion intensity values normalized to a gallic acid internal standard are 
listed with data ranges in parentheses. (attached) 
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Supporting information 
Supporting figures 
 
Figure S 2. Ultraviolet-visible spectra of yerba mate extract (0.16 mg/ml tea; “low” 
concentration) with FeSO4 or FeCl3 at varying concentrations. Points are the means of technical 
duplicates; one representative biological replicate is shown. Arrows indicate the tendency of 
absorbance to shift up or down corresponding with increasing or decreasing iron concentrations. 
 
96 
 
 
 
Figure S 3. Saturation assays are plotted for A. Fe
2+
 (FeSO4) and B. Fe
3+
 (FeCl3); absorbance 
was monitored at 380 nm. No ferrozine was added for this assay. Experiments were done at least 
in duplicate; error bars represent standard deviation. Tea concentrations were 0.32 mg/ml 
(“high”) and 0.16 mg/ml (“low). 
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CHAPTER V  
METABOLIC ANALYSIS OF THE MECHANISMS OF ACTION OF 
YERBA MATE EXTRACT ON SALMONELLA ENTERICA SEROVAR 
TYPHIMURIUM 
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Abstract   
Salmonella enterica serovar Typhimurium is a Gram-negative enteropathogen that infects 
millions of people worldwide each year; the rapid emergence of antibiotic resistant strains has 
heightened the urgency to develop effective treatments for this pathogen. Aqueous extracts of 
yerba mate (Ilex paraguariensis) provide effective therapy, in vitro, for the drug-resistant S. 
Typhimurium DT104. Unfortunately, while some of the chemical constituents that contribute to 
the extract’s antibacterial activity have been identified, the mechanism of action of the extract is 
still unknown and of crucial importance to its future potential in combating antibiotic resistant 
bacteria. Yerba mate extract induced changes in central carbon metabolism in S. Typhimurium, 
reduced catalase activity by means other than direct inhibition, and did not change membrane 
integrity (except at the initial 0 time point, where differences were not resolved) despite a 
significant increase in the production of a cell wall precursor. Additional significant differences 
were observed in the global metabolic regulators alpha-ketoglutarate and acetylphosphate, the 
energy-related molecule NAD
+
, and in an unexpected match to the antibacterial compound 
yohimbine. This work provides the first evaluation of the mechanism of action of yerba mate 
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extract on S. Typhimurium, revealing a major impact on central carbon metabolism, catalase 
activity, and possible metabolic links to interference in energy production and membrane 
integrity. The putative identification of the antibacterial compound yohimbine and the many 
unidentified compounds provides additional avenues for future investigations of novel yerba 
mate compounds capable of traversing or binding to S. Typhimurium’s membrane. 
Introduction 
Nontyphoidal Salmonella species are widespread food-borne enteropathogens responsible for 
more than one million infections annually in the United States alone (S. Crim et al., 2015; 
Scallan et al., 2011). The cost of these infections places a significant burden on the U.S. 
healthcare system, leading to over 2,000 hospitalizations and 30 deaths per year (S. Crim et al., 
2015; Scallan et al., 2011). Perhaps of even greater concern, Salmonella enterica serotype 
Typhimurium accounts for approximately 12% of serotyped Salmonella infections in the U.S. (S. 
Crim et al., 2015), and strains have emerged that are reported to be resistant to the most common 
antimicrobial agents (CDC, 2015). The emergence of drug resistance in this globally relevant 
pathogen highlights the need to identify new antibacterial agents, and serves as the motivation 
for this work. 
One source of novel antibacterial agents is plants, which have evolved to produce 
numerous biologically active chemicals. At present, antibacterial agents derived from plants are 
not a major source for pharmaceutical-grade antibiotics, likely due to the generally higher 
minimum inhibitory concentrations compared to bacterial-derived antibiotics (discussed by 
Tegos & Stermitz, 2002), concerns over quality control (Yau, Goh, & Koh, 2015), and 
difficulties in obtaining intellectual property for natural products (Silins, Tan, & Chan, 2015). 
Despite these concerns, plants contain many weakly antibiotic compounds that may act 
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synergistically to increase the efficacy of other antibiotics (Lewis & Ausubel, 2006). One 
example of synergism in plant antibiotics are the barberry plants (Berberis), which produce the 
antibiotic berberine that is only effective in the presence of a multidrug resistance pump 
inhibitor, like the phytochemical 5’-methoxyhydnocarpin (Tegos & Stermitz, 2002). This 
synergistic mechanism of action shows a level of complexity not readily observed in synthetic 
pharmaceutical systems. In addition to synergistic mechanisms, single plant antibacterial 
compounds, such as eugenol (Devi, Nisha, Sakthivel, & Pandian, 2010), ferulic acid (Borges et 
al., 2013), and essential oils (Bakkali et al. 2008), have been shown to be involved in membrane 
disruption, production of reactive oxygen species (ROS), and inhibition of transcription,  
translation, and DNA replication (Abreu et al., 2012; Cowan, 1999; Radulović, Blagojević, 
Stojanović-Radić, & Stojanović, 2013; Upadhyay, Upadhyaya, Kollanoor-Johny, & 
Venkitanarayanan, 2014). In plant antibacterial compounds, the ability to disrupt the bacterial 
membrane/cell wall, as assayed by monitoring efflux of intracellular components, influx of 
hydrophobic dyes or antibiotics, or microscopic observation, has been frequently attributed to 
polyphenolics (Borges et al., 2015; Cushnie & Lamb, 2011; Devi et al., 2010; Di Pasqua et al., 
2007; Gill & Holley, 2006; Helander et al., 1998; Lambert, Skandamis, Coote, & Nychas, 2001; 
Nohynek et al., 2006; Tyagi, Singh, Kumari, Kumari, & Mukhopadhyay, 2015). Similarly, plant 
polyphenols have been implicated in the formation of ROS in bacteria, based on colorimetric or 
fluorescent dyes (Dwyer, Collins, & Walker, 2015; Nakamura et al., 2015; Zhao, Hong, & 
Drlica, 2014). Inhibition of proteins, such as FtsZ (Hwang & Lim, 2015) and DNA gyrase 
(Plaper et al., 2003), or direct binding to DNA (Lou et al., 2012; Plaper et al., 2003) by plant 
extracts have been less studied, but have been shown to be important to the generation of 
antibacterial activity in some systems. As bacteria continue to develop resistance to current 
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pharmaceuticals, alternative compounds will be necessary to quell this threat, with plants 
providing a vast resource of novel compounds with various modes of action.  
The goal of this study was to examine the mechanism of action of an aqueous extract of 
yerba mate, a leaf tea made from Ilex paraguariensis, on Salmonella Typhimurium. Previous 
studies have demonstrated the antibacterial activity of yerba mate against a wide range of 
foodborne bacterial pathogens (Burris et al., 2011, 2012, 2015; Hongpattarakere, 2000; Kubo & 
Muroi, 1993; Martin et al., 2013; Sari, Turkmen, Polat, & Velioglu, 2007; Tsai, Tsai, Chien, Lee, 
& Tsai, 2008). Yerba mate is known to contain numerous antibacterial phenolic compounds, 
including chlorogenic acids, quercetin, and ferulic acids (Heck & De Mejia, 2007). While pure 
phenolic compounds isolated from yerba mate have been investigated for their antibacterial 
modes of action (Martin et al., 2013), no studies have examined the antibacterial mechanism of 
the whole extract. In this work, membrane disruption, catalase activity, and the metabolomic 
profiles of Salmonella Typhimurum DT104 in response to a sub-lethal concentration of yerba 
mate extract was examined.  
Results 
At a starting S. Typhimurium concentration of ca. 6 log colony forming units (CFU)/ml, the 
minimum inhibitory concentration (MIC) of yerba mate was found to be 10 mg/ml based on 
killing at 24 hours (h) (Figure 9A). At concentrations < 2.5 mg/ml, a lag in growth was observed 
over the first 4 h of culture, with the cultures fully recovering by 8 h. This lag was more 
pronounced at 5 mg/ml with the cultures failing to reach the culture maximum over the 24 h 
period of the experiments. When the starting concentration of S. Typhimurium was increased to 
ca. 9 log in order to obtain sufficient cell quantities for subsequent assays, a MIC was not 
observed over the tested concentration range; however, at a dose of 80 mg/ml yerba mate, there 
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was a significant reduction in growth after 2 h, thus this dose was termed the sub-lethal dose 
(Figure 9B). For simplicity, the three S. Typhimurium treatment conditions with ca. 9 log 
CFU/ml starting culture conditions will be referred to as controlno tea (0 mg/ml yerba mate extract 
with S. Typhimurium), tea (80 mg/ml yerba mate extract with S. Typhimurium), and controlno 
bacteria (80 mg/ml yerba mate extract with phosphate buffered saline (PBS) pH 7.4 instead of S. 
Typhimurium) throughout the remainder of this paper.  
No significant differences between controlno tea and tea treatments were observed in 
measurements of optical density at 600 nm (OD600), so the crystal violet assay was not adjusted 
to OD600 (Figure S 4). The crystal violet assay for membrane integrity showed no significant 
differences between controlno bacteria compared to tea except at the initial timepoint (Figure 10B), 
so the significant differences that were observed between controlno tea and tea can generally be 
explained by the interaction of yerba mate extract with crystal violet. Thus, no change in 
membrane integrity was detected with this assay except for a possible unresolved loss of 
membrane integrity immediately after the tea treatment was applied. Catalase activity, however, 
was observed to be reduced in the tea treatment as compared to the controlno tea treatment. No 
effect of controlno bacteria was observed on catalase (Figure 10A).  
The intracellular metabolomics analysis showed that 20 to 34 identifiable metabolites 
were significantly different in each of the six displayed treatment comparisons (tea vs. controlno 
tea at 0, 40, and 240 min and tea vs. controlno bacteria at 0, 40, and 240 min) that focus on 
differences between the tea treatment and control treatments at each time point (Table 9, Table 
10, Table 11, Table 12, Table 13, Table 14). The tricarboxylic acid (TCA) cycle (Figure 11) was 
the pathway most enriched by the identifiable compounds in Tables 9-14.  
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The pentose phosphate pathway (PPP) (Figure S 5), glycolysis pathways (Figure 12), and 
amino acid and nucleotide biosynthesis/metabolism (Figure S 6, Figure S 7) were also 
represented in the identifiable compounds with significant differences between tea and control 
treatments. Two identifiable compounds with significant differences between tea and controls, 
yohimbine and ornithine, were observed to be present only in tea and not in controlno tea (Figure 
13, Figure S 7). As seen in the plots of succinate/methylmalonate, fumarate, and malate, some 
common metabolic products are also clearly present in the tea treatment (Figure 11). In a brief 
summary of treatment differences, there were 7 compounds with significant differences between 
tea and both controls at 0 min, 15 compounds at 40 min, and 10 compounds at 240 min (Tables 
9-14). Among these compounds, aconitate, citraconate, citrate/isocitrate, flavin mononucleotide 
(FMN), fumarate, and N-carbamoyl-L-aspartate were significantly different between tea and 
both control treatments at 0 min and at 40 min Acetylphosphate, alpha-ketoglutarate, 
sedoheptulose 1/7-phosphate, and valine were significantly different between tea and both 
controls at 40 min and at 240 min; there were no compounds significantly different between tea 
and both controls across all three time points (Tables 9-14).  
Discussion 
The MIC of yerba mate was 10 mg/ml with ca. 6 log CFU/ml starting culture based on killing at 
24 h (Figure 9A). This was similar to the 7.4 mg/ml MIC previously observed (Gonzalez-gil et 
al., 2014) with aqueous yerba mate extract and S. Typhimurium DT104. An MIC of 10 mg/ml is 
much higher than the µg/ml-level MICs of antibiotics currently in use, but is comparable to the 
S. Typhimurium MICs of other plant extracts, which were observed to range from 0.78 to 6.25 
mg/ml (Marasini et al., 2015). Variation between manufacturers’ batches  (Golozar et al., 2012) 
would be expected to contribute to differences in MIC between studies. There is a known 
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“inoculum effect” such that antibiotic susceptibility is reduced when the bacterial inoculum 
concentration is increased. This was observed when the S. Typhimurium inoculum concentration 
was increased to ca. 9 log CFU/ml in order to obtain enough biomass for assays in the current 
study (Figure 9B). The inoculum effect was previously observed with multiple antibiotic classes, 
including aminoglycosides, beta-lactams, and fluoroquinolones in studies that focused on 
Escherichia coli and Staphylococcus aureus (Greulich, Scott, Evans, & Allen, 2015; Udekwu, 
Parrish, Ankomah, Baquero, & Levin, 2009; zur Wiesch et al., 2015). S. Typhimurium inoculum 
effects have been characterized with beta-lactams (Eng, Cherubin, Smith, & Buccini, 1985) but 
recent work with inoculum effects has primarily focused on E. coli and S. aureus.  
Yerba mate contains a diverse mixture of compounds, including polyphenolics, 
xanthines, alkaloids, and flavonoids, that likely contribute to its antioxidant, stimulant, 
antibacterial, and other bioactive properties (reviewed by Heck & De Mejia, 2007). The 
antibacterial mechanisms of many specific plant constituents such as eugenol or ferulic acid have 
been studied with assays for membrane integrity, reactive oxygen species, and binding to key 
proteins (Borges et al., 2013; Devi et al., 2010).  Membrane integrity is traditionally assayed by 
monitoring efflux of intracellular components, influx of hydrophobic dyes or antibiotics, or 
microscopic observation and has generally been found to contribute to the antibacterial 
mechanism of polyphenolics (Borges et al., 2015; Cushnie & Lamb, 2011; Devi et al., 2010; Di 
Pasqua et al., 2007; Gill & Holley, 2006; Helander et al., 1998; Lambert et al., 2001; Nohynek et 
al., 2006; Tyagi et al., 2015), although quercetin has been observed to increase cell wall rigidity 
(T. Wu, He, et al., 2013). The crystal violet membrane integrity assay used in the current study 
revealed that the major differences between tea and controlno tea treatments could be explained by 
a precipitate of the tea interacting with crystal violet dye, as evidenced by the controlno bacteria 
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treatment (Figure 10B). The only significant difference between tea and controlno bacteria occurred 
at the initial 0 min time point (Figure 10B), which suggests that there could be a slight, 
immediate change in membrane integrity upon addition of the tea treatment (the tea treatment 
took up more crystal violet than the controlno tea or controlno bacteria treatments) that occurred too 
quickly for this experiment to resolve.  
ROS assays based on colorimetric or fluorescent dyes are also common and generally conclude 
that phenolics promote ROS formation (Dwyer et al., 2015; Nakamura et al., 2015; Zhao et al., 
2014). The current work hypothesized that yerba mate extract would follow a noted trend of 
increased ROS with antibacterial activity (Kohanski, Dwyer, Hayete, Lawrence, & Collins, 
2007), which would in turn upregulate the expression of catalase. Catalase activity of bacterial 
cells, however, was determined to be significantly reduced with the tea treatment compared to 
the controlno tea treatment at 0 h, 4 h, and 8 h (Figure 10A). Again, the difference at 0 h suggests 
fluctuation on a time scale smaller than this experiment was able to accurately measure. The 
consistently reduced catalase activity of S. Typhimurium in the tea treatment was not due to the 
direct inhibition of catalase by the tea extract (Table S 9), but could be a result of transcriptional, 
translational, or post-translational control of tea components. Since yerba mate extract is well 
known for its high antioxidant activity (Filip, Lotito, Ferraro, & Fraga, 2000; Valerga, Reta, & 
Lanari, 2012; Valerga, Shorthose, & Lanari, 2013), it is also possible that ROS species were 
reduced by the tea, thus triggering a downregulation of catalase by S. Typhiumurium. 
Additional phenolic mechanisms of action of that were not tested in this work include 
binding to specific proteins like FtsZ (Hwang & Lim, 2015) and DNA gyrase (Plaper et al., 
2003) or direct binding to DNA (Lou et al., 2012; Plaper et al., 2003). Complex plant extracts, 
including berries (reviewed by Puupponen-Pimiä et al. 2005) and essential oils (reviewed by 
106 
 
Bakkali et al. 2008) have been evaluated for mechanisms of action, especially membrane 
integrity, ROS production, and protein binding. Three edible medicinal plants (Yong, Ooh, Ong, 
Chai, & Wong, 2015) were recently evaluated for their mechanisms of action using proteomic 
analyses of bacterial pathogens, but to our knowledge, the current study was the first to survey 
the metabolome of pathogenic bacteria in order to gain an understanding of a plant extract’s 
antibacterial mechanism(s). Bacterial metabolomics has been shown to be capable of 
differentiating classes of common pharmaceutical antibiotics (Belenky, Ye, Porter, Schwarz, et 
al., 2015; Dörries, Schlueter, & Lalk, 2014) and evaluating pure phytochemicals (Mousavi, 
Bojko, Bessonneau, & Pawliszyn, 2016) but has not previously been applied to plant extracts. 
The metabolomics assessment of S. Typhimurium (Table 9-14, Figures 11, 12, S 5-S7) must be 
interpreted carefully since the “intracellular” metabolites of cells collected on filters were 
evaluated, meaning that the controlno bacteria sample consisted of tea components that adhered to 
the filter rather than all possible components in the tea. Thus, metabolites that are absent from 
controlno bacteria may still be present in the tea extract; metabolites that are present in the controlno 
bacteria treatment were definitely present in the tea extract, but not necessarily at the same 
concentration observed. Thus, the tea and control treatments have the potential to contain an 
intracellular metabolite, a metabolite bound extracellularly, and metabolites adhered to the filter. 
The metabolomics results are additionally limited by which metabolites are identifiable and the 
possibility that mechanisms of action may either non-specifically alter the metabolome or not 
impact the metabolome at all (as observed in Vincent, Ehmann, Mills, Perros, & Barrett, 2016). 
Based on the results from the metabolomics data, there are three categories that the significantly 
different metabolites could fall under: 1) influx from the tea extract, 2) general stress conditions, 
and/or 3) antibiotic specific stressors.  
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Influx from tea extract 
A significantly larger mean in tea vs. controlno tea followed by a decrease over time in the tea 
treatment, as in citrate/isocitrate and aconitate of the tricarboxylic acid (TCA) cycle (Table 9-11, 
Figure 11), is a common trend that may signify an immediate cellular response, but may also be 
due to the influx of that metabolite into the cell from the tea extract. Yohimbine in particular can 
be confidently explained by influx from the tea since it is not known to be produced by S. 
Typhimurium and is absent from the controlno tea treatment. Succinate, fumarate, and malate may 
also be transported into the cell from the tea extract and either join in the TCA cycle or, more 
likely, inhibit the progression of the TCA cycle since most TCA cycle products act as inhibitors 
through feedback regulation.  
General stress conditions 
Lag and exponential growth phases differ, with lag phase showing slow growth and increased 
expression of metal uptake and oxidative stress systems (Rolfe et al., 2012), but this should not 
impact the results of the current study since both controlno tea and tea are in lag phase at 40 min 
and late exponential phase at 4 h. Osmolarity, however, was expected to be a factor in the 
response of S. Typhimurium to the tea treatment, but common osmoprotectants like glutamate 
and proline (discussed by Frossard et al., 2012) were observed to have no significant differences 
between treatments, and other osmoprotectants were not identified. Additionally, oxidative stress 
effects were expected, but not observed in the metabolomics data. For example, glutathione to 
glutathione disulfide ratios, associated with oxidative stress conditions (reviewed by Pompella, 
Visvikis, Paolicchi, De Tata, & Casini, 2003), had no significant differences compared to the 
controls, and glutathione disulfide was not observed. Other key indicators of oxidative stress, 
like 8-oxo-guanine (reviewed by Farr & Kogoma, 1991), were not present in the library of 
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standards used for compound identification, thus it was not possible to analyze their levels. One 
generic stress response is the downregulation of genes needed for cell growth, but specific 
stressors tend to give specific responses, especially with metabolomics data (Jozefczuk et al., 
2010). In general, the later stages of the TCA cycle (succinate/methylmalonate, malate, 
fumarate) were the only cell growth-related steps that appeared to be static. Without flux 
information, the static appearance of these compounds could be due to constant movement as 
they are converted to the next metabolite, or it could be due to no movement at that portion of the 
TCA cycle. There are few entirely generic metabolic stress responses, but downregulation of the 
latter portion of the TCA cycle is one that might be at work in the current study. 
Antibiotic specific stressors 
Stress-specific trends in antibiotic-treated bacteria have previously been used to identify 
mechanisms of the antibiotic (Belenky, Ye, Porter, Schwarz, et al., 2015; Dörries et al., 2014; 
Vincent et al., 2016). In E. coli treated with norfloxacin, kanamycin, or ampicillin, no key 
distinguishing features were visible at 30 min, but large increases in levels of citrate, succinate, 
and oxidized nicotinamide adenine dinucleotide (NAD
+ 
) and decreases in nucleotide precursors 
(including ribose 5-phosphate) were observed for all the tested antibiotics (Belenky, Ye, Porter, 
Schwarz, et al., 2015). The current study did not observe any of these trends at 40 min. Similarly, 
trends in nucleotides, cell wall precursors, and other metabolites that were previously seen to 
define a thymidine kinase inhibitor and a 1-deoxy D-xylulose 5-phosphate (DXR) pathway 
inhibitor (Vincent et al., 2016) were not observed in the significantly different metabolites of the 
current work.  
UDP-N-acetylglucosamine is a lipid precursor that normally favors conversion to acyl-
ACP; however, in the presence of an inhibitor of LpxC, the enzyme at the following step of lipid 
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A synthesis, acyl-ACP accumulates and may push the reverse reaction to convert it back to UDP-
N-acetylglucosamine (Barb & Zhou, 2008; reviewed by Mcclerren et al., 2005). In the current 
work, UDP-N-acetylglucosamine was significantly higher in the tea treatment at 40 min but not 
different at 240 min, so it is possible that lipid A synthesis was blocked, causing acyl-ACP (not 
in library of standards) accumulation and pushing a reverse reaction to UDP-N-
acetylglucosamine, which might have transiently risen at 40 min before being shuttled to other 
pathways. Membrane integrity effects would be expected if lipid A synthesis was blocked, so 
concentrations of the inhibitor may have been too low relative to cell concentrations to have a 
visible membrane effect under the tested conditions. The difference in membrane integrity seen 
at 0 min supports an immediate membrane effect that is quickly overcome due to the large 
number of bacterial cells, but a faster membrane integrity assay is needed to resolve the time 
scale of any membrane effects and ensure equivalent starting conditions.  
Significant differences in amino acids and nucleotides between controlno tea and tea were 
only observed with valine (decreased in tea at 240 min) and cytidine monophosphate (increased 
in tea at 240 min), suggesting interference or specific regulation of enzymes unique to valine and 
CMP synthesis or metabolism. However, no enzymes were noted to be unique to valine or CMP 
synthesis based on KEGG pathways (Kanehisa & Goto, 2000). CMP might also increase due to 
higher levels of RNA degradation, but other nucleotides would be expected to increase if this 
were the case. UMP, AMP, GMP, and IMP had noisy spectral abundance data that might show 
significant trends with additional replication. 
Respiration occurs in the plasma membrane of Salmonella species, and uses the 
membrane-bound NADH complex, succinate dehydrogenase, and lactate dehydrogenase to 
gather electrons. Electrons are then passed to ubiquinone or another electron acceptor, powering 
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proton pumps that create the gradient needed for ATP synthase to function. NADH use by the 
NADH complex is the most efficient electron source since it is furthest from the final electron 
acceptor, capable of generating 3 ATP compared to 2 from succinate dehydrogenase. Flavin 
mononucleotide (FMN) and flavin adenine dinucleotide (FAD) are also important in electron 
transfer and frequently serve as cofactors in biosynthesis functions. The NADH complex 
contains a FMN cofactor and the succinate dehydrogenase complex holds an FAD cofactor. FAD 
levels were not different between tea and controlno tea, and the slightly elevated FMN levels at 0 
and 40 min could be explained by immediate influx from the tea extract. NAD
+
, however, had a 
significant increase of 0.7 fold at 240 min, which, although a small fold-change, amounts to a 5 
log difference in abundance based on spectral intensity units (Table 11, Figure 13). NADH was 
not visible in these data and so it is presumed to have been used immediately after being 
produced. The higher levels of NAD
+
 observed in tea vs. controlno tea might signify slowed 
NADH production. Most NADH is produced in glycolysis, the pentose phosphate pathway 
(PPP), and the TCA cycle, the pathways in which the most differences in metabolites between 
treatments were observed. All TCA cycle enzymes with the exception of isocitrate 
dehydrogenase are known to be downregulated during lag phase, which is associated with ROS 
stress (Rolfe et al., 2012). The TCA enzymes following isocitrate dehydrogenase, which 
produces alpha-ketoglutarate, have no significant changes and thus could be down-regulated by 
the stress of yerba mate extract. This would leave the TCA cycle to produce only a single NADH 
from isocitrate dehydrogenase. Glycolysis showed no significant differences in pyruvate or 
acetyl CoA, the substrate and product for the NADH formation step. In the PPP 6-
phosphogluconate, the precursor to an NADH reaction, is elevated at 0 and 240 min, which 
might be expected to increase NADH production. Based on these results, a reduced TCA cycle 
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would have the greatest impact on NADH production, but flux data would be needed to test 
whether the TCA cycle has been truncated or has constant flux under the tea treatment 
conditions. 
Additional significantly different metabolites of particular interest are alpha-
ketoglutarate, phosphoenolpyruvate (PEP), and acetylphosphate. Alpha-ketoglutarate has an 
unusual trend in which it is significantly greater than the controlno tea treatment at both 40 min 
(2.1 fold higher) and 240 min (1.3 fold higher). As a key regulator and signaling molecule for 
both carbon and nitrogen metabolism, alpha-ketoglutarate alterations can be very influential. 
Alpha-ketoglutarate inhibits glucose transporters (Doucette, Schwab, Wingreen, & Rabinowitz, 
2011), PEP synthetase (Chulavatnatol & Atkinson, 1973), and citrate synthase (Pereira, Donald, 
Hosfields, & Harry, 1994), so it may be responsible for the decrease in citrate over time after an 
initial high production rate or influx from the tea. Citrate could also be decreasing over time due 
to efflux from the cell by pumps that remove citrate-iron complexes from ROS-stressed cells 
(Frawley et al., 2013). Glucose-6-phosphate, a direct product of glucose, was not observed to 
differ between tea and controlno tea, but PEP increased at 240 min, perhaps in response to the 
reduction of alpha-ketoglutarate in the tea treatment between 40 and 240 min. Since alpha-
ketoglutarate is a key intermediate in amino acid synthesis and degradation, the elevated levels 
of alpha-ketoglutarate may also have been a response to high turnover in amino acids or simply 
an overload of citrate and isocitrate from the tea that fluxed to alpha-ketoglutarate. While amino 
acids other than valine, which is derived from pyruvate, showed no significant differences 
between treatments, the production and consumption could have been higher in the tea treatment 
and required additional alpha-ketoglutarate levels to be maintained. 
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PEP and pyruvate are also major intermediates that regulate flux into the TCA cycle and 
other cellular pathways. No significant differences in pyruvate were observed between 
treatments, but PEP accumulated in the tea treatment at 240 min. This was unexpected since 
increased pyruvate has been associated with recovery from environmental stressors (Morishige, 
Fujimori, & Amano, 2013; J. Wu, Li, Cai, & Jin, 2014), but here the precursor to pyruvate, PEP, 
and a product of pyruvate, acetylphosphate, were observed to significantly increase while 
pyruvate had no significant difference (though there is a non-significant trend of increasing 
pyruvate in tea vs. controlno tea) (Figure 11, Figure 12). When there is excess glucose, pyruvate 
tends to flow to acetylphosphate and then to acetate that is excreted in “overflow metabolism” 
(Wolfe 2005). When glucose is less abundant, acetate is taken back up and converted to 
acetylphosphate and then to pyruvate or acetyl-coA. Acetylphosphate also acts as a global 
signaling molecule for nitrogen assimilation and biosynthesis of flagella, pili, capsule, and 
biofilm components (reviewed for E. coli in Wolfe, 2005). The accumulation of acetylphosphate 
in tea at 240 min could mark the switch between glucose and glucose/acetate metabolism 
delayed from the 40 min accumulation of acetylphosphate in controlno tea. Another possible 
explanation is that acetylphosphate production was upregulated for its signaling functions, 
particularly those involving membrane proteins since UDP-N-acetylglucosamine levels were 
increased at the same time.  
Overall, most of the changes in identifiable compounds revealed that S. Typhimurium 
with the tea treatment was forced to handle an abundance of metabolic intermediates, which may 
have prompted differential production of the major regulatory metabolites alpha-ketoglutarate 
and acetylphosphate. An immediate metabolic response or influx from the tea may have been 
responsible for elevated levels of metabolites, but neither can be verified without a flux analysis. 
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At lower inoculum levels, the relatively higher concentrations of metabolic intermediates may 
backlog the TCA cycle, glycolysis, and the PPP, since intermediates tend to act as feedback 
inhibitors, resulting in minimal levels of NADH production, reduced respiration, and thus 
reduced energy production. This cell state could leave S. Typhimurium more vulnerable to 
abnormalities in membrane synthesis and any toxic effects of unusual tea metabolites like 
yohimbine (Table 9) and the many unknown compounds that may have entered the cell (Table S 
10). Yohimbine is known to have strong antibacterial activity against E. coli (MIC 4-32 µg/ml) 
and had no cytotoxic effects on two different cell lines (Ozçelik et al., 2011). The compound 
found in the current study is a match to yohimbine, but since yohimbine has not previously been 
found in any processed or unprocessed Ilex paraguariensis samples, it may be a related 
compound with the same chemical formula (C21H26N2O3). Vincamine (Pubchem compound 
identifier (CID) 15376), rauwolscine (CID 643606), corynanthine (CID 92766), and 
epivincamine (CID 637570) are all isomers of yohimbine; some are found in Rauwolfia ssp. 
(Chatterjee et al., 1956) and Aspidosperma quebracho-blanco (Ewins, 1914) in South America. 
Conclusion 
Yerba mate extract contains potentially novel components that are capable of killing major 
bacterial pathogens like S. Typhimurium, but only mechanistic information on previously known 
pure components, not the comprehensive whole extract (including potentially novel compounds), 
was available prior to this work. Now it is clear that yerba mate extract has a major impact on 
central carbon metabolism, including the TCA cycle, PPP, and glycolysis pathways, by either 
stimulating an immediate response or presenting the cells with large quantities of metabolic 
intermediates that could block NADH production. Furthermore, catalase activity was reduced in 
the presence of the tea at 240 min, but not directly inhibited, which suggests that catalase was 
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downregulated due to effects of tea components or reduced ROS in the cell. Finally, this study 
has found that membrane integrity was unaffected in the conditions tested, but UDP-N-
acetylglucosamine, a cell wall precursor, and acetylphosphate, a global signaling compound that 
can regulate membrane proteins were both upregulated at 240 min. This suggests that membrane 
stress may be visible with a lower relative concentration of bacterial cells to tea compounds. This 
first step toward characterizing the antibacterial activity of yerba mate extract has ruled out 
several previously known mechanisms based on metabolomic trends and contributed information 
on cell membrane integrity, catalase activity, altered S. Typhimurium metabolism, and putatively 
identified yohimbine and a list of unidentifiable yerba mate components compounds capable of 
entering or binding to S. Typhimurium cells. Future studies can now build on this knowledge to 
generate more specific hypotheses of antibacterial mechanism for yerba mate extract and its 
constituents and examine yohimbine and the set of currently unidentified compounds for their 
individual and synergistic antibacterial mechanisms of action. 
Materials and methods 
 Yerba mate aqueous extraction 
A commercial brand of yerba mate tea (Taragui; 100% leaves, Argentina) was homogenized in a 
blender to a particle size of <1 mm to be consistent with previous aqueous yerba mate studies 
(Burris et al., 2012; Rempe et al., 2015). The homogenized tea was then extracted with ten times 
its mass of water at 4 °C for 3.5 h, 0.22 μm polyethersulfone (PES) vacuum filtered (Corning 
Life Sciences, Oneonta, NY, USA), frozen at -80 °C, and lyophilized using a FreeZone, 12 L 
freeze dryer (Labconco, Kansas City, Mo. USA). Dried extracts were stored at room temperature 
in a sealed plastic container prior to testing.   
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Bacterial culture maintenance 
S. Typhimurium DT104 strain 2576 was obtained from the Department of Food Science and 
Technology at the University of Tennessee. Stock cultures of S. Typhimurium strains were 
stored in 25% glycerol at -20 °C. Cultures were started from frozen stocks and re-inoculated 
daily in tryptic soy broth (TSB) for 2-3 days before an experiment. To score the CFUs at a given 
time interval, 100 μl samples were serially diluted in 0.1% sterile peptone and pour-plated in 
duplicate using tryptic soy agar (TSA). S. Typhimurium plates were grown aerobically at 37 °C 
for 24 h. Following incubation, CFUs were enumerated.  
Bacterial growth experiments 
Yerba mate extract (12.5 mg to 2 g) was reconstituted in MOPS buffer pH 7.3, adjusted to a final 
pH of 7.3 with 1 M KOH, and syringe-filtered through 0.22 μm Express PES Membrane 
(Millipore, Billerica, Mass., USA) prior to microbial susceptibility testing.  All growth 
experiments were performed in 125 ml flasks containing 12.5 ml TSB, 10 ml reconstituted yerba 
mate extract or MOPS buffer pH 7.3, and 2.5 ml bacteria for a total volume of 25 ml. Overnight 
bacterial cultures were diluted in 0.1 % sterile peptone to obtain 2.5 ml of ca. 5-6 log CFU/ml 
starting concentrations or 5 ml of ca. 20 h culture was pelleted at 15,000 x g for 1 min at 4 °C, 
the supernatant decanted, and the pellet resuspended in 5 ml PBS pH 7.4  to achieve a ca. 9 log 
CFU/ml starting concentration. A no-bacteria control contained 2.5 ml PBS pH 7.4. Experiments 
were conducted aerobically at 37 °C with shaking at 150 rpm. Initial growth experiments were 
assessed at yerba mate extract concentrations of 0, 1.25, 2.5, 5, 10, 15, and 20 mg/ml yerba mate 
extract with time points of 0, 4, 8, 12, and 24 h.  
For mechanistic assays, experiments started with ca. 9 log CFU/ml cells to ensure 
sufficient cells for assays. At this high cell density, no difference in mechanistic assays or growth 
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was observed between yerba mate concentrations of 0 mg/ml, 10 mg/ml, 20 mg/ml, or 40 mg/ml, 
so 80 mg/ml yerba mate extract was the treatment used for all mechanistic assays.  Time points 
ranged from 0-2 h for membrane integrity assays and 0-8 h for catalase activity assays. Up to 3 
samples (1.5 ml for catalase activity, 700 μl for membrane integrity and biomass, and 100 μl for 
CFU counts) were taken from each flask for mechanistic assays. Metabolomics extractions were 
taken at times 0, 40 min (lag phase), and 4 h (exponential phase, significant difference in catalase 
activity) in addition to samples for catalase activity, OD600, and CFU enumeration.  
Crystal violet membrane integrity assay: 
 For membrane integrity and biomass, a 700 μl sample from a flask with or without bacteria 
treated with yerba mate extract or MOPS buffer was taken, pelleted at 15,000 × g at 4 °C for 1 
min, and washed at least three times with 500 μl PBS pH 7.4. The final pellet was resuspended in 
700 μl PBS pH 7.4 and thoroughly vortexed. Two 200 μl samples were taken from each 
resuspended pellet, put in a 96-well plate, and OD600 was read. The remaining 500 μl was again 
pelleted at 15,000 × g at 4 °C for 1 min, the supernatant removed, and the pellet resuspended in 
500 μl of 0.001% crystal violet freshly diluted in PBS pH 7.4 from a 1% aqueous solution. The 
crystal violet tubes were vortexed and incubated for 10 min at 37 °C, pelleted at 15,000 × g, and 
two 100 μl samples of the supernatant were added to a 96-well plate and read at crystal violet’s 
absorbance wavelength of 590 nm. A blank sample of the crystal violet solution was used to 
calculate percent of crystal violet uptake (((blank – sample)/blank) * 100)) (modified from Devi, 
Nisha, Sakthivel, & Pandian, 2010).  
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Catalase activity assay 
A 1.5 ml sample from a flask with or without bacteria treated with yerba mate extract or MOPS 
buffer was pelleted at 15,000 × g for 1 min at 4 °C and washed 3 times with 500 μl PBS pH 7.4.  
The final pellet was resuspended in 300 μl PBS pH 7.4 and thoroughly vortexed. A simple foam 
assay (Iwase et al., 2013) was conducted, in which 100 μl PBS pH 7.4, 100 μl washed sample in 
PBS pH 7.4, 100 μl 1% Triton X-100 in PBS pH 7.4, and 100 μl of cold 30 % hydrogen peroxide 
were added to a glass tube and mixed well. Technical duplicates were made for each sample. A 
standard curve was made by reconstituting 0.0050 g catalase powder (Fisher, Nazareth, Penn., 
USA; 20000 U/g) in 1 ml PBS pH 7.4, then serially diluting to get 0, 2.5, 5, 7.5, and 10 catalase 
activity units. Foam height (cm) was measured after foam had stabilized. 
Metabolomics 
Starting cultures had ca. 9 log CFU/ml cells or PBS pH 7.4 for media controls and 0 or 80 mg/ml 
buffered yerba mate extract. At times 0, 40 min, and 4 h, 500 μl of cells were removed, diluted in 
4.5 ml PBS pH 7.4, mixed, and vacuum filtered with 0.4 μm polycarbonate filters. The filters 
were placed face-down in 1.3 ml cold (20 °C) extraction solvent (4:4:2 AcN:MeOH:H2O) for 20 
min at 20 °C. In a 4 °C cold room, any remaining cells were washed from the filter with 400 μl 
extraction solvent and pelleted at 16,200 × g for 5 min. All extraction solvent fractions for a 
single sample were combined, dried under flowing nitrogen, resuspended in 300 μl of milliQ 
water, and transferred to a centrifuge tube. Six biological replicates were done, but 
contamination found in CFU plates prompted the exclusion of 3 replicates.  
All samples were randomized in a 4 ˚C autosampler tray, from which 10 µl aliquots were 
injected into a Synergi 2.5 micron Hydro-RP 100, 100 × 2.00 mm liquid chromatography column 
(Phenomenex) maintained at 25 ˚C. A gradient across solvents A (97:3 water:methanol, 10 mM 
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tributylamine, and 15 mM acetic acid ) and B (methanol) was run with 0% B for 5 min, 20 % B 
for 8 min, 55% B for 2.5 min, 95% B for 3.5 min, and finally 0 % B for 6 min using a 200 µl/min 
flow rate.  The column eluted to an electrospray ionization (ESI) source coupled to a mass 
spectrometer by a 0.1 mm internal diameter fused silica capillary tube. A Thermo Scientific 
Exactive Plus orbitrap mass spectrometer was run in fullscan mode with negative ionization 
using a published method (Lu et al., 2010). Instrument parameters were set to a spray voltage of 
3 kV, a nitrogen sheath gas flow of 10 psi with a capillary temperature of 320 ˚C, an automatic 
gain control (AGC) target of 3e6, a resolution of 140,000, a scan window of 85 to 800 m/z from 
0 to 9 min and a scan window of 110 to 1000 m/z from 9 to 24 min.  
Data analysis 
Growth experiments were each set up and analyzed as a randomized block design, blocked on 
replicate with sampling in duplicate. Treatment design was repeated measures with concentration 
applied to each flask and time applied within each flask. Experiments were replicated three 
times. Bacterial growth data were analyzed by analysis of variance (ANOVA) using mixed 
models (SAS 9.4, SAS Institute, Cary, N.C., USA). Least significant differences (LSD) were 
used to compare treatment mean values when significant differences (P<0.05) were found. Error 
bars in all growth plots represent standard deviations of at least 3 replicates. 
Metabolomics data analysis 
Data was converted from Thermo .raw files to .mzML using msconvert from ProteoWizard 
(Chambers, Maclean, & Burke, 2012).  Peak selection was done with MAVEN (Melamud, 
Vastag, & Rabinowitz, 2010) version 767 using the default model. Additional parameters are 
listed in Table S 8. Peak intensity data in the resulting data matrix was normalized to biomass by 
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scaling the intensity for each sample. All samples were arbitrarily scaled to the intensity value of 
the first sample (7.35 × 10
8
 CFU/ml counts). To investigate treatment and time differences, the 
data matrix was analyzed as a randomized block design, blocked on replicate, with split plots of 
time. A split plot analysis was considered sufficient when the change in Akaike information 
criterion (AIC) was less than 3 between a repeated measures model with an adjusted correlation 
structure (AR1) and a split plot model without a defined correlation structure. In 131 of the 7693 
untargeted metabolites that were normal and had equal variance, the change in AIC was greater 
than 3, so a repeated measures correlation structure was used in those cases. The three flask 
treatments were controlno tea (0 mg/ml yerba mate extract with S. Typhimurium), tea (80 mg/ml 
yerba mate extract with S. Typhimurium), and controlno bacteria (80 mg/ml yerba mate extract with 
PBS pH 7.4 instead of bacteria). ANOVA assumptions were tested in R with the Levene test for 
equal variance (P>0.05) and the Shapiro-Wilks test for normality (W>0.80). If these assumptions 
were not met or if errors occurred in the lme analysis (i.e. “computationally singular matrix”), 
metabolites were not included in the analysis. Otherwise, data were analyzed using linear mixed 
models (package nlme, R Foundation for Statistical Computing, Vienna, Austria). P-values were 
collected from a Tukey’s honestly significant difference (HSD) analysis implemented with the R 
glht function from the multcomp package. Six contrast statements are displayed in the results 
tables to focus on differences between controls (no tea or no bacteria) and the tea treatment. 
Tukey HSD p-values were adjusted for multiple comparisons with the Benjamini-Hochberg 
method (false discovery rate 0.05, R function p.adjust) as a single family across all metabolites. 
ANOVA p-values across treatments were adjusted with the Benjamini-Hochberg correction as a 
separate group across all metabolites. Metabolites with an ANOVA p-value of P< 0.05 across all 
treatments that additionally had a Tukey HSD contrast p-value of P<0.05 were ranked by the 
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most positive to most negative fold-change in the results tables. Both targeted (limited to 
identifiable compounds) and untargeted analyses were performed, but only results from the 
targeted analysis are displayed in Tables 9-14. Additional information for the targeted results is 
in Table S 11 and all untargeted results are in Table S 10. Metabolites were identified based on 
an in-house library of 257 compounds that had been run as pure standards on the same 
instrument and with the same methods used for the samples. Names were matched to peaks 
within 5 ppm m/z and 1.5 min of the observed m/z and retention time of the pure standard. If 
multiple peaks were within the range of a single compound, the peak closest to the observed 
retention time that did not appear to be a shoulder peak was selected for Tables 9-14 and Figures 
11-13, S 5-S 7). All original multiply assigned peaks are in Table S 10 and Table S 11.  
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Appendix 
Figures 
 
Figure 9. Growth of S. Typhimurium with A. ca. 6 log CFU/ml starting culture and 0 to 20 
mg/ml yerba mate extract (n=3) or with B. ca. 9 log CFU/ml starting culture and 0 to 80 mg/ml 
yerba mate extract (n=3 for 0.5 and 1 h and n=7 for all other time points). Error bars show 
standard deviation. Statistically significant differences are marked by an asterisk for B only 
(RBD repeated measures ANOVA).  
128 
 
 
Figure 10. S. Typhimurium bioassays under controlno tea, tea, and controlno bacteria treatments to 
test A. catalase activity with a simple foam assay and B. membrane integrity based on the uptake 
of crystal violet dye. Error bars show standard deviation. Statistically significant differences 
between controlno tea and tea in A or between controlno bacteria and tea in B are marked by an 
asterisk (RBD repeated measures ANOVA). n=4 for both A and B. 
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Figure 11. TCA cycle with plots displaying abundance of identifiable metabolites in three yerba 
mate extract treatments (controlno tea, tea, controlno bacteria) and at three timepoints (0, 40, 240 min). 
Asterisks mark significant differences between one control treatment at a single time point and 
the tea treatment at the corresponding time point. The citrate plot shows pooled results for 
citrate/isocitrate and the succinate plot shows pooled results for succinate/methylmalonate since 
these metabolite groups are indistinquishable with the methods used. Error bars represent 95% 
confidence intervals. n=3 
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Figure 12. Glycolysis pathways with plots displaying abundance of identifiable metabolites in 
three yerba mate extract treatments (controlno tea, tea, controlno bacteria) and at three timepoints (0, 
40, 240 min). Asterisks mark significant differences between one control treatment at a single 
time point and the tea treatment at the corresponding time point. Error bars represent 95% 
confidence intervals. n=3 
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Figure 13. Metabolites that are included in the discussion but not in the TCA cycle or glycolysis 
pathways. Plots display abundance of identifiable metabolites in three yerba mate extract 
treatments (controlno tea, tea, controlno bacteria) and at three timepoints (0, 40, 240 min). Asterisks 
mark significant differences between one control treatment at a single time point and the tea 
treatment at the corresponding time point. Error bars represent 95% confidence intervals. n=3 
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Tables 
Table 9. Significant differences between controlno_tea and tea at 0 min 
  
mz rt Putative name Fold change  Mean diff. Pathways/Notes 
353.1861 12.25 Yohimbine >6223 6223 Found in plant extracts  
383.1158 5.49 S-Adenosyl-L-homocysteine 107.31 54606 Cysteine and methionine metabolism 
179.0559 6.22 myo-Inositol 7.13 1007861 Galactose, ascorbate, aldarate metab 
179.0346 12.96 Hydroxyphenylpyruvate 6.83 78289 Phe, Tyr, Trp, and quinone biosynth 
209.0305 12.17 D-Glucarate 6.43 918498 Ascorbate and aldarate metabolism 
195.0511 5.13 D-Gluconate 5.93 463201 Ascorbate and aldarate metabolism 
168.9812 12.53 Sulfolactate 5.68 358020 Cysteine and methionine metabolism 
133.0143 11.66 Malate 5.59 17120480 TCA 
191.02 12.76 Citrate/isocitrate 5.5 33537521 TCA; Ala, Asp, Glu metabolism 
173.0089 13.14 Aconitate 5.31 2896247 TCA 
115.0033 12.55 Fumarate 5.01 1551875 TCA, Arg, Tyr, Phe, pyruvate, nicotinate 
metab. 
157.0366 1.3 Allantoin 4.75 146091 Purine metabolism 
175.0609 13.16 2-Isopropylmalate 4.63 272415 Pyruvate metab.; Val, Leu, Ile biosynth. 
175.0244 6.47 Ascorbate 4.25 7640 Ascorbate and aldarate metab, PTS 
213.0172 6.85 Deoxyribose phosphate 4.13 3983 PPP, pyrimidine metabolism 
341.1095 1.34 Trehalose/Sucrose/Cellobiose 3.44 420093 Starch and sucrose metabolism 
129.019 13.13 Citraconate 2.85 141501 Val, Leu, Ile biosynthesis 
275.0177 12.41 6-Phospho-D-gluconate 2.43 393914 PPP 
177.0401 6.86 Gluconolactone 2.37 27661 PPP 
117.0191 10.91 Succinate/Methylmalonate 1.8 12531083 TCA, Ala, Asp, Glu, Tyr, Phe, pyruvate 
metab. 
105.019 5.52 Glycerate 1.54 472651 PPP, Gly,Ser,Thr, metabolism 
157.0255 6.52 Dihydroorotate 1.43 3289 Pyrimidine biosynthesis 
565.0484 12.38 UDP-glucose 1.37 309874 Starch, sucrose; ascorbate, aldarate; 
pyrimidine metab. 
455.0977 14.43 FMN 1.24 4980 Flavin biosynthesis, respiration 
153.0193 12.55 2_3-Dihydroxybenzoate 1.07 20796 Aromatic amino acid, quinone, 
enterobactin metabolism 
163.0399 15.03 Phenylpyruvate -1.78 -9904 Phe biosynthesis 
175.0358 11.46 N-Carbamoyl-L-aspartate -2.36 -89246 Pyrimidine biosynthesis 
mz = mass to charge ratio 
rt = retention time 
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract 
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea 
”controlno_bacteria” refers to tea with PBS pH 7.4  instead of bacteria 
Fold change is expressed as log2(control/tea) 
Mean difference is the difference between the adjusted intensity means of control – tea 
 PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system 
 UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine 
dinucleotide  
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Table 10. Significant differences between controlno_tea and tea at 40 min 
   
mz rt Putative name Fold change  Mean diff. Pathways/Notes 
383.1158 5.49 S-Adenosyl-L-homocysteine 108.01 73846 Cysteine and methionine metabolism 
353.1861 12.25 Yohimbine 60.41 5392 Found in plant extracts  
179.0346 12.96 Hydroxyphenylpyruvate 52.08 57363 Phe, Tyr, Trp, and quinone biosynth 
157.0366 1.3 Allantoin 7.63 154804 Purine metabolism 
179.0559 6.22 myo-Inositol 7.35 1027983 Galactose, ascorbate, aldarate metab 
209.0305 12.17 D-Glucarate 6.84 972917 Ascorbate and aldarate metabolism 
168.9812 12.53 Sulfolactate 6.4 279361 Cysteine and methionine metabolism 
133.0143 11.66 Malate 5.75 13629865 TCA 
195.0511 5.13 D-Gluconate 5.75 439500 PPP 
191.02 12.76 Citrate/isocitrate 5.47 26177730 TCA; Ala, Asp, Glu metabolism 
175.0244 6.47 Ascorbate 5.01 8597 Ascorbate and aldarate metab, PTS 
115.0033 12.55 Fumarate 4.97 1659376 TCA, Arg, Tyr, Phe, pyruvate metabolism 
173.0089 13.14 Aconitate 4.75 2074842 TCA, glyoxylate metabolism 
175.0609 13.16 2-Isopropylmalate 3.45 103004 Val, Leu, Ile, pyruvate metabolism 
341.1095 1.34 Trehalose/Sucrose/Cellobiose 3.2 333984 Starch and sucrose metabolism 
117.0191 10.91 Succinate/Methylmalonate 2.49 13280583 TCA,Ala,Asp,Glu,Tyr,Phe,pyruvate 
metab, 
129.019 13.13 Citraconate 2.19 95207 Val, Leu, Ile biosynthesis 
177.0401 6.86 Gluconolactone 2.18 23413 PPP 
145.0143 12.16 alpha-Ketoglutarate 2.13 3145953 TCA, amino acid and quinone  biosynth 
455.0977 14.43 FMN 1.79 7469 Flavin biosynthesis, respiration 
105.019 5.52 Glycerate 1.61 411390 PPP, Gly,Ser,Thr, metabolism 
116.0714 1.11 Valine 1.6 407 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
288.1204 7.56 Ophthalmate 0.86 110577 Cysteine and methionine metabolism 
606.075 12.42 UDP-N-acetylglucosamine 0.68 105219 Lipopolysaccharide, peptidoglycan 
biosynth; amino and nucleotide sugar 
metab. 
115.0398 12.39 2-Oxoisovalerate -0.62 -100110 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
168.9906 9.32 Dihydroxyacetone phosphate -0.68 -124034 Glycolysis, gluconeogenesis 
131.0825 1.23 Ornithine -1.29 -3130 Arg biosynth; Arg and Pro metabolism 
368.9995 12.75 Sedoheptoluse bisphosphate -1.36 -20176 PPP 
319.0438 7.17 Octulose 8/1P -1.37 -6145 Methylthiolincosamide biosynthesis 
258.0388 1.49 Glucosamine phosphate -1.67 -12173 Ala, Asp, Glu metab; PTS; amino and 
nucleotide sugar metab 
157.0255 6.52 Dihydroorotate -1.88 -7081 Pyrimidine biosynthesis 
163.0399 15.03 Phenylpyruvate -1.94 -32315 Phe biosynthesis 
138.98 11.8 Acetylphosphate -2.21 -8842 Taurine, pyruvate, carbon metab 
175.0358 11.46 N-Carbamoyl-L-aspartate -5.52 -1720323 Pyrimidine biosynthesis 
mz = mass to charge ratio 
rt = retention time 
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract 
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea 
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Table 10 notes continued 
 
”controlno_bacteria” refers to tea with PBS pH 7.4  instead of bacteria 
Fold change is expressed as log2(control/tea) 
Mean difference is the difference between the adjusted intensity means of control – tea 
 PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system 
 UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine 
dinucleotide  
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Table 11. Significant differences between controlno_tea and tea at 240 min 
 
mz rt Putative name Fold change  Mean diff. Pathways/Notes 
179.0559 6.22 myo-Inositol 8.13 1745217 Galactose, ascorbate, aldarate metab 
289.0333 7.24 Sedoheptulose 1/7-phosphate 6.26 654240 PPP, lipopolysaccaride biosynthesis 
322.0449 9.04 CMP 5.77 267595 Pyrimidine metabolism 
175.0244 6.47 Ascorbate 5.38 7728 Ascorbate and aldarate metab, PTS 
115.0033 12.55 Fumarate 5.37 1092892 TCA, Arg, Tyr, Phe, pyruvate, nicotinate 
metab. 
133.0143 11.66 Malate 4.28 6963500 TCA 
138.98 11.8 Acetylphosphate 4.04 11563 Taurine, pyruvate, carbon metab 
175.0609 13.16 2-Isopropylmalate 3.7 24484 Val, Leu, Ile, pyruvate metabolism 
117.0191 10.91 Succinate/Methylmalonate 3.38 13699174 TCA,Ala,Asp,Glu,Tyr,Phe,pyruvate 
metab, 
166.9751 13.06 Phosphoenolpyruvate 3.36 241253 TCA, glycolysis, gluconeogenesis, PTS, 
Phe, Tyr, Tryp biosynth 
177.0401 6.86 Gluconolactone 3.04 13053 PPP 
153.0193 12.55 2_3-Dihydroxybenzoate 2.98 28200 Aromatic amino acid, quinone, 
enterobactin metabolism 
275.0177 12.41 6-Phospho-D-gluconate 2.31 4789 PPP 
129.019 13.13 Citraconate 1.75 22694 Val, Leu, Ile biosynthesis 
258.0388 1.49 Glucosamine phosphate 1.56 11003 Ala, Asp, Glu metab; PTS; amino and 
nucleotide sugar metab 
115.0398 12.39 2-Oxoisovalerate 1.45 112597 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
145.0143 12.16 alpha-Ketoglutarate 1.35 391899 TCA, amino acid and quinone  biosynth 
662.1028 8.8 NAD+ 0.7 103153 Respiration, thiamine metabolism 
173.0929 1.49 N-Acetylornithine -2.08 -61697 Arginine biosynthesis 
116.0714 1.11 Valine -3.73 -1787 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
mz = mass to charge ratio 
rt = retention time 
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract 
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea 
”controlno_bacteria” refers to tea with PBS pH 7.4  instead of bacteria 
Fold change is expressed as log2(control/tea) 
Mean difference is the difference between the adjusted intensity means of control – tea 
 PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system 
 UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine 
dinucleotide  
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Table 12. Significant differences between controlno_bacteria and tea at 0 min 
 
mz rt Putative name Fold change  Mean diff. Pathways/Notes 
115.0398 12.39 2-Oxoisovalerate -0.64 -55405 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
146.0459 4.72 Glutamate -1.73 -6966631 Arg, Ala, Asp, Glu, Pro, His, Taurine, 
glutathione metabolism 
191.02 12.76 Citrate/isocitrate -1.8 -2.4E+07 TCA; Ala, Asp, Glu metabolism 
175.0609 13.16 2-Isopropylmalate -2.06 -215728 Pyruvate metab.; Val, Leu, Ile biosynth. 
129.019 13.13 Citraconate -2.28 -130526 Val, Leu, Ile biosynthesis 
173.0929 1.49 N-Acetylornithine -2.69 -18970 Arginine biosynthesis 
166.9751 13.06 Phosphoenolpyruvate -2.74 -13749 TCA, glycolysis, gluconeogenesis, PTS, 
Phe, Tyr, Tryp biosynth 
288.1204 7.56 Ophthalmate -2.91 -252922 Cysteine and methionine metabolism 
175.0358 11.46 N-Carbamoyl-L-aspartate -2.97 -18771 Pyrimidine biosynthesis 
115.0033 12.55 Fumarate -3 -1401927 TCA, Arg, Tyr, Phe, pyruvate, nicotinate 
metab. 
565.0484 12.38 UDP-glucose -3.78 -469416 Starch, sucrose; ascorbate, aldarate; 
pyrimidine metab. 
173.0089 13.14 Aconitate -4 -2785595 TCA 
662.1028 8.8 NAD+ -4 -99637 Respiration, thiamine metabolism 
455.0977 14.43 FMN -4.71 -8292 Flavin biosynthesis, respiration 
116.0714 1.11 Valine -5.68 -9527 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
145.0143 12.16 alpha-Ketoglutarate -5.69 -418654 TCA, amino acid and quinone  biosynth 
275.0177 12.41 6-Phospho-D-gluconate -5.82 -474798 PPP 
368.9995 12.75 Sedoheptoluse bisphosphate -5.92 -10829 PPP 
229.0119 7.15 Ribose phosphate -6.13 -17148 PPP, purine metabolism 
168.9906 9.32 Dihydroxyacetone phosphate -9.46 -176509 Glycolysis, gluconeogenesis 
784.152 15.1 FAD -50.77 -3943 Riboflavin metabolism, respiration 
138.98 11.8 Acetylphosphate -103.07 -2147 Taurine, pyruvate, carbon metab 
131.0825 1.23 Ornithine -103.09 -546 Arg biosynth; Arg and Pro metabolism 
mz = mass to charge ratio 
rt = retention time 
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract 
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea 
”controlno_bacteria” refers to tea with PBS pH 7.4  instead of bacteria 
Fold change is expressed as log2(control/tea) 
Mean difference is the difference between the adjusted intensity means of control – tea 
 PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system 
 UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine 
dinucleotide  
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Table 13. Significant differences between controlno_bacteria and tea at 40 min 
 
mz rt Putative name Fold change  Mean diff. Pathways/Notes 
115.0398 12.39 2-Oxoisovalerate -0.95 -89485 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
116.0714 1.11 Valine -1.43 -383 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
191.02 12.76 Citrate/isocitrate -1.6 -1.8E+07 TCA; Ala, Asp, Glu metabolism 
129.019 13.13 Citraconate -1.69 -84205 Val, Leu, Ile biosynthesis 
146.0459 4.72 Glutamate -2.39 -7653190 Arg, Ala, Asp, Glu, Pro, His, Taurine, 
glutathione metabolism 
455.0977 14.43 FMN -3.57 -9620 Flavin biosynthesis, respiration 
173.0089 13.14 Aconitate -3.66 -1985077 TCA 
163.0399 15.03 Phenylpyruvate -3.7 -10513 Phe biosynthesis 
322.0449 9.04 CMP -3.9 -7209 Pyrimidine metabolism 
115.0033 12.55 Fumarate -3.98 -1605564 TCA, Arg, Tyr, Phe, pyruvate, nicotinate 
metab. 
166.9751 13.06 Phosphoenolpyruvate -4.38 -19162 TCA, glycolysis, gluconeogenesis, PTS, 
Phe, Tyr, Tryp biosynth 
368.9995 12.75 Sedoheptoluse bisphosphate -4.47 -12248 PPP 
784.152 15.1 FAD -4.6 -6412 Riboflavin metabolism, respiration 
259.0227 6.66 Glucose 6-phosphate -4.8 -205988  
289.0333 7.24 Sedoheptulose 1/7-phosphate -4.88 -22783 PPP, lipopolysaccaride biosynthesis 
175.0358 11.46 N-Carbamoyl-L-aspartate -5.11 -37308 Pyrimidine biosynthesis 
229.0119 7.15 Ribose phosphate -5.83 -16429 PPP, purine metabolism 
565.0484 12.38 UDP-glucose -6.59 -797530 Starch, sucrose; ascorbate, aldarate; 
pyrimidine metab. 
138.98 11.8 Acetylphosphate -6.73 -2407 Taurine, pyruvate, carbon metab 
606.075 12.42 UDP-N-acetylglucosamine -6.81 -275975 Lipopolysaccharide, peptidoglycan 
biosynth; amino and nucleotide sugar 
metab. 
275.0177 12.41 6-Phospho-D-gluconate -6.86 -437177 PPP 
288.1204 7.56 Ophthalmate -7.58 -244381 Cysteine and methionine metabolism 
145.0143 12.16 alpha-Ketoglutarate -9.45 -4073374 TCA, amino acid and quinone  biosynth 
168.9906 9.32 Dihydroxyacetone phosphate -10.51 -206741 Glycolysis, gluconeogenesis 
321.0495 10.62 dTMP -50.38 -914 Pyrimidine metabolism 
131.0825 1.23 Ornithine <-2177 -2177 Arg biosynth; Arg and Pro metabolism 
mz = mass to charge ratio 
rt = retention time 
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract 
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea 
”controlno_bacteria” refers to tea with PBS pH 7.4  instead of bacteria 
Fold change is expressed as log2(control/tea) 
Mean difference is the difference between the adjusted intensity means of control – tea 
 PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system 
 UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine 
dinucleotide  
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Table 14. Significant differences between controlno bacteria and tea at 240 min 
 
mz rt Putative name Fold change  Mean diff. Pathways/Notes 
213.0172 6.85 Deoxyribose phosphate 3.12 6161 PPP, pyrimidine metabolism 
191.02 12.76 Citrate/isocitrate 3.07 16187946 TCA; Ala, Asp, Glu metabolism 
177.0401 6.86 Gluconolactone 2.29 57692 PPP 
116.0714 1.11 Valine 2.26 553 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
179.0346 12.96 Hydroxyphenylpyruvate 1.53 29855 Phe, Tyr, Trp, and quinone biosynth 
105.019 5.52 Glycerate 1.51 486848 PPP, Gly,Ser,Thr, metabolism 
341.1095 1.34 Trehalose/Sucrose/Cellobiose 1.45 242645 Starch and sucrose metabolism 
115.0398 12.39 2-Oxoisovalerate -0.65 -64809 Val, Leu, Isoleu biosynth; pantothenate 
and coA biosynth 
179.0559 6.22 myo-Inositol -1.22 -1001285 Galactose, ascorbate, aldarate metab 
321.0495 10.62 dTMP -1.53 -1093 Pyrimidine metabolism 
157.0255 6.52 Dihydroorotate -1.99 -3939 Pyrimidine biosynthesis 
173.0929 1.49 N-Acetylornithine -2.64 -16085 Arginine biosynthesis 
455.0977 14.43 FMN -3.36 -8022 Flavin biosynthesis, respiration 
163.0399 15.03 Phenylpyruvate -3.77 -29757 Phe biosynthesis 
662.1028 8.8 NAD+ -4.33 -254901 Respiration, thiamine metabolism 
168.9906 9.32 Dihydroxyacetone phosphate -4.7 -18053 Glycolysis, gluconeogenesis 
145.0143 12.16 alpha-Ketoglutarate -5.51 -629579 TCA, amino acid and quinone  biosynth 
322.0449 9.04 CMP -6.03 -268434 Pyrimidine metabolism 
289.0333 7.24 Sedoheptulose 1/7-phosphate -6.49 -655535 PPP, lipopolysaccaride biosynthesis 
166.9751 13.06 Phosphoenolpyruvate -6.83 -265009 TCA, glycolysis, gluconeogenesis, PTS, 
Phe, Tyr, Tryp biosynth 
258.0388 1.49 Glucosamine phosphate -8.21 -16604 Ala, Asp, Glu metab; PTS; amino and 
nucleotide sugar metab 
175.0358 11.46 N-Carbamoyl-L-aspartate -8.28 -879679 Pyrimidine biosynthesis 
138.98 11.8 Acetylphosphate -105.41 -12313 Taurine, pyruvate, carbon metab 
131.0825 1.23 Ornithine -106.24 -1211 Arg biosynth; Arg and Pro metabolism 
mz = mass to charge ratio 
rt = retention time 
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract 
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea 
”controlno_bacteria” refers to tea with PBS pH 7.4  instead of bacteria 
Fold change is expressed as log2(control/tea) 
Mean difference is the difference between the adjusted intensity means of control – tea 
 PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system 
 UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine 
dinucleotide  
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Supporting information 
Supporting figures 
 
Figure S 4. Optical density at 600 nm of S. Typhimurium under 3 treatment types (controlno tea, 
tea, controlno bacteria). There were no significant differences between controlno tea and tea 
treatments. Error bars represent standard deviation. n=4 
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Figure S 5. Pentose phosphate pathway with plots displaying abundance of identifiable 
metabolites in three yerba mate extract treatments (controlno tea, tea, controlno bacteria) and at three 
timepoints (0, 40, 240 min). Asterisks mark significant differences between one control 
treatment at a single time point and the tea treatment at the corresponding time point. Error bars 
represent 95% confidence intervals. n=3 
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Figure S 6. Valine, leucine, and isoleucine biosynthesis pathway with plots displaying 
abundance of identifiable metabolites in three yerba mate extract treatments (controlno tea, tea, 
controlno bacteria) and at three timepoints (0, 40, 240 min). Asterisks mark significant differences 
between one control treatment at a single time point and the tea treatment at the corresponding 
time point. Error bars represent 95% confidence intervals. n=3 
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Figure S 7. Additional metabolites with significant differences between treatments;  plots 
display abundance of identifiable metabolites in three yerba mate extract treatments (controlno tea, 
tea, controlno bacteria) and at three timepoints (0, 40, 240 min). Asterisks mark significant 
differences between one control treatment at a single time point and the tea treatment at the 
corresponding time point. Error bars represent 95% confidence intervals. n=3 
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Supporting tables 
Table S 8. Peak-picking parameters for metabolomics data analysis with Maven software. These 
parameters were used for both targeted and untargeted analyses but targeted analyses were 
limited to identifiable compounds. 
Parameter Value 
Mass domain resolution 5 ppm 
Time domain resolution 10 scans 
EIC smoothing 3 scans 
Peak grouping (maximum group retention time difference) 0.50 min 
Drop top x% intensities to get baseline 80% 
Baseline smoothing 10 scans 
Peak classifier model default.model 
Minimum good peaks/group 3 
Minimum signal/baseline ratio 5 
Minimum peak width 10 scans 
Minimum signal/blank ratio 5 
Minimum  peak intensity 10000 ions 
 
 
144 
 
 
Table S 9. Pure catalase tested for activity in the presence of yerba mate extract (controlno 
bacteria ). Pure catalase (5 U) in buffer was compared to pure catalase (5 U) with incubated 
yerba mate extract (controlno bacteria). No significant difference was observed between 
catalase in buffer and catalase treated with incubated yerba mate extract sampled at 
different times.  
    
 
 
 
  
A. Average standard catalase curve 
B. Average catalase activity with controlno 
bacteria 
Activity 
units 
Foam 
height 
 
Time 
(minutes) 
Foam 
height 
0 0 ± 0 
 
0 1.54 ± 0.18 
2.5 0.73 ± 0.04 
 
40 1.58 ± 0.11 
5 1.53 ± 0.04   100 1.58 ± 0.09 
7.5 2.35 ± 0.07 
 
120 1.58 ± 0.09 
10 3.1 ± 0.14 
 
240 1.53 ± 0.08 
   
480 1.54 ± 0.05 
 
Foam height (cm)  ± standard deviation 
n=4 for average catalase activity with controlno bacteria 
n=2 for standard curves since experiments were run in parallel in sets of 2 
5 activity units of pure catalase (boxed in standard curve table) were tested for catalase activity 
after the addition of 50 µl of controlno bacteria treatment from 0 to 8 hours 
There was no significant difference (P=0.97) in foam height between pure catalase treated with 
the controlno bacteria treatment (5 activity units) and pure catalase under standard testing conditions 
(5 activity units) with the non-parametric Kruskal-Wallis test (R function ‘kruskal.test’ used with 
the ‘interaction’ function to expand model to a one-way design) that was used to account for 
unequal variance from unbalanced data. 
 
Table S 10. Complete list of all metabolites found with LC-MS. (attachment) 
Table S 11. List of all identified metabolites found with LC-MS. (attachment) 
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CHAPTER VI  
CONCLUSION 
 
The increasing prevalence of multi-drug resistant bacterial pathogens threatens to return us to a 
pre-antibacterial era if we fail to find new antibacterial compounds or alternative treatments. 
Nevertheless, we are lucky to have an immense, diverse pool of phytochemicals to draw from in 
our search for antibacterials. Many plant extracts are already known to have some degree of 
antibacterial activity, but information on the constituents contributing to antibacterial activity and 
their mechanisms of action are needed to push the field forward. This dissertation makes a small 
step in this direction by seeking the major chemical components with antibacterial activity and 
assaying yerba mate extract for a series of potential antibacterial mechanisms of action. A 
preliminary review of the literature for antibacterial mechanisms of action of phenolic 
compounds discussed a role for systems biology as a means of screening for novel mechanisms 
of action. Then, using a unique search method, GC-MS metabolite data from forty-two fractions 
of yerba mate extract were each characterized for antibacterial activity against MRSA and S. 
aureus and compounds were ranked by their contribution to the discrimination of antibacterial 
from non-antibacterial activities. Based on this assessment, 5-hydroxy-pipecolic acid and quinic 
acid were found to be candidates for involvement in antibacterial activity against MRSA, 
although pure 3, 4-dihydroxybenzaldehyde showed the best antibacterial activity of the pure 
compounds assayed. Moving to a different system, this work next surveyed the accumulated 
metabolic products of L. casei and S. Typhimurium when grown with yerba mate extract in a 
milk system. While few notable changes were observed in the significantly accumulated 
metabolic products of either L. casei or S. Typhimurium, the presence of increased oxalomalate 
in S. Typhimurium suggested inhibition of aconitase. The hypothesis of phenolic chelation as a 
possible mechanism of action based on knowledge of phenolic chelation tendencies revealed that 
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the presence of exogenous iron sulfate prompted the partial recovery of S. Typhimurium. Next, 
after shifting from S. Typhimurium in a milk system to a common growth media for further 
mechanistic assessments, bioassays revealed that cell membrane integrity was not definitively 
changed but catalase activity was reduced in the presence of yerba mate extract. Furthermore, 
altered abundances of metabolites were observed in central carbon metabolism, a cell wall 
precursor, two metabolic regulators, an energy molecule, and a hit to the known antibacterial 
compound yohimbine. We anticipate that the continuing work in the areas of antibacterial 
discovery and mechanisms will lead to a better understanding of how antibacterial compounds 
function and how resistance mechanisms can be dealt with. 
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